{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:05:59Z","timestamp":1792814759401,"version":"4.5.0"},"reference-count":309,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12016-017-8633-4","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T10:51:18Z","timestamp":1501843878000},"page":"26-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":203,"title":["Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management"],"prefix":"10.1007","volume":"54","author":[{"given":"Kyle T.","family":"Amber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedee F.","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Borradori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,4]]},"reference":[{"key":"8633_CR1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/s0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt E, Zillikens D (2013) Pemphigoid diseases. Lancet 381:320\u2013332. doi: 10.1016\/s0140-6736(12)61140-4","journal-title":"Lancet"},{"key":"8633_CR2","doi-asserted-by":"publisher","first-page":"e432","DOI":"10.1111\/ijd.12492","volume":"53","author":"AB Serwin","year":"2014","unstructured":"Serwin AB, Musialkowska E, Piascik M (2014) Incidence and mortality of bullous pemphigoid in north-east Poland (Podlaskie Province), 1999-2012: a retrospective bicentric cohort study. Int J Dermatol 53:e432\u2013e437. doi: 10.1111\/ijd.12492","journal-title":"Int J Dermatol"},{"key":"8633_CR3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/bjd.13189","volume":"171","author":"AK Forsti","year":"2014","unstructured":"Forsti AK, Jokelainen J, Timonen M, Tasanen K (2014) Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital. Br J Dermatol 171:1223\u20131226. doi: 10.1111\/bjd.13189","journal-title":"Br J Dermatol"},{"key":"8633_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaad.2014.02.030","volume":"71","author":"KE Brick","year":"2014","unstructured":"Brick KE, Weaver CH, Lohse CM, Pittelkow MR, Lehman JS, Camilleri MJ, Al-Hashimi M, Wieland CN (2014) Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009. J Am Acad Dermatol 71:92\u201399. doi: 10.1016\/j.jaad.2014.02.030","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","volume":"161","author":"G Marazza","year":"2009","unstructured":"Marazza G, Pham HC, Scharer L, Pedrazzetti PP, Hunziker T, Trueb RM, Hohl D, Itin P, Lautenschlager S, Naldi L, Borradori L (2009) Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol 161:861\u2013868. doi: 10.1111\/j.1365-2133.2009.09300.x","journal-title":"Br J Dermatol"},{"key":"8633_CR6","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1610-0387.2008.06976.x","volume":"7","author":"F Bertram","year":"2009","unstructured":"Bertram F, Brocker EB, Zillikens D, Schmidt E (2009) Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 7:434\u2013440. doi: 10.1111\/j.1610-0387.2008.06976.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"8633_CR7","doi-asserted-by":"publisher","first-page":"a180","DOI":"10.1136\/bmj.a180","volume":"337","author":"SM Langan","year":"2008","unstructured":"Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J (2008) Bullous pemphigoid and pemphigus vulgaris\u2014incidence and mortality in the UK: population based cohort study. BMJ 337:a180. doi: 10.1136\/bmj.a180","journal-title":"BMJ"},{"key":"8633_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1365-2133.2005.06662.x","volume":"153","author":"VS Gudi","year":"2005","unstructured":"Gudi VS, White MI, Cruickshank N, Herriot R, Edwards SL, Nimmo F, Ormerod AD (2005) Annual incidence and mortality of bullous pemphigoid in the Grampian region of North-east Scotland. Br J Dermatol 153:424\u2013427. doi: 10.1111\/j.1365-2133.2005.06662.x","journal-title":"Br J Dermatol"},{"key":"8633_CR9","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/jid.2012.35","volume":"132","author":"P Joly","year":"2012","unstructured":"Joly P, Baricault S, Sparsa A, Bernard P, Bedane C, Duvert-Lehembre S, Courville P, Bravard P, Remond B, Doffoel-Hantz V, Benichou J (2012) Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol 132:1998\u20132004. doi: 10.1038\/jid.2012.35","journal-title":"J Invest Dermatol"},{"key":"8633_CR10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","volume":"41","author":"M Jung","year":"1999","unstructured":"Jung M, Kippes W, Messer G, Zillikens D, Rzany B (1999) Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 41:266\u2013268","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR11","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","volume":"136","author":"F Hubner","year":"2016","unstructured":"Hubner F, Recke A, Zillikens D, Linder R, Schmidt E (2016) Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany. J Invest Dermatol 136:2495\u20132498. doi: 10.1016\/j.jid.2016.07.013","journal-title":"J Invest Dermatol"},{"key":"8633_CR12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jaad.2014.05.006","volume":"71","author":"JH Lee","year":"2014","unstructured":"Lee JH, Kim SC (2014) Mortality of patients with bullous pemphigoid in Korea. J Am Acad Dermatol 71:676\u2013683. doi: 10.1016\/j.jaad.2014.05.006","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR13","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/bjd.12806","volume":"170","author":"SC Cai","year":"2014","unstructured":"Cai SC, Allen JC, Lim YL, Chua SH, Tan SH, Tang MB (2014) Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre. Br J Dermatol 170:1319\u20131326. doi: 10.1111\/bjd.12806","journal-title":"Br J Dermatol"},{"key":"8633_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1684\/ejd.2012.1906","volume":"23","author":"LM Zhang","year":"2013","unstructured":"Zhang LM, Wu J, Xiao T, Jin GY, Li JH, Geng L, He CD, Gao XH, Chen HD (2013) Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study. Eur J Dermatol 23:94\u201398. doi: 10.1684\/ejd.2012.1906","journal-title":"Eur J Dermatol"},{"key":"8633_CR15","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/jdv.12065","volume":"28","author":"A Gual","year":"2014","unstructured":"Gual A, Mascaro JM Jr, Rojas-Farreras S, Guilabert A, Julia M, Iranzo P (2014) Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre. J Eur Acad Dermatol Venereol 28:500\u2013506. doi: 10.1111\/jdv.12065","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8633_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000345625","volume":"225","author":"B Cortes","year":"2012","unstructured":"Cortes B, Khelifa E, Clivaz L, Cazzaniga S, Saurat JH, Naldi L, Borradori L (2012) Mortality rate in bullous pemphigoid: a retrospective monocentric cohort study. Dermatology 225:320\u2013325. doi: 10.1159\/000345625","journal-title":"Dermatology"},{"key":"8633_CR17","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/j.1365-4632.2011.05227.x","volume":"51","author":"AT Baibergenova","year":"2012","unstructured":"Baibergenova AT, Weinstock MA, Shear NH (2012) Mortality from acquired bullous diseases of skin in Canadian adults 2000-2007. Int J Dermatol 51:1325\u20131328. doi: 10.1111\/j.1365-4632.2011.05227.x","journal-title":"Int J Dermatol"},{"key":"8633_CR18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1365-2133.2011.10413.x","volume":"165","author":"B Cortes","year":"2011","unstructured":"Cortes B, Marazza G, Naldi L, Combescure C, Borradori L (2011) Mortality of bullous pemphigoid in Switzerland: a prospective study. Br J Dermatol 165:368\u2013374. doi: 10.1111\/j.1365-2133.2011.10413.x","journal-title":"Br J Dermatol"},{"key":"8633_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamadermatol.2013.5757","volume":"150","author":"F Fichel","year":"2014","unstructured":"Fichel F, Barbe C, Joly P, Bedane C, Vabres P, Truchetet F, Aubin F, Michel C, Jegou J, Grange F, Antonicelli F, Bernard P (2014) Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study. JAMA Dermatol 150:25\u201333. doi: 10.1001\/jamadermatol.2013.5757","journal-title":"JAMA Dermatol"},{"key":"8633_CR20","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","volume":"138","author":"B Rzany","year":"2002","unstructured":"Rzany B, Partscht K, Jung M et al (2002) Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. Arch Dermatol 138:903\u2013908","journal-title":"Arch Dermatol"},{"key":"8633_CR21","doi-asserted-by":"publisher","unstructured":"Ren Z, Hsu DY, Brieva J, Silverberg NB, Langan SM, Silverberg JI (2016) Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A. Br J Dermatol. 10.1111\/bjd.14821","DOI":"10.1111\/bjd.14821"},{"key":"8633_CR22","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jaad.2015.01.029","volume":"72","author":"YW Phoon","year":"2015","unstructured":"Phoon YW, Fook-Chong SM, Koh HY, Thirumoorthy T, Pang SM, Lee HY (2015) Infectious complications in bullous pemphigoid: an analysis of risk factors. J Am Acad Dermatol 72:834\u2013839. doi: 10.1016\/j.jaad.2015.01.029","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/1346-8138.12175","volume":"40","author":"JS Lehman","year":"2013","unstructured":"Lehman JS, Khunger M, Lohse CM (2013) Infection in autoimmune bullous diseases: a retrospective comparative study. J Dermatol 40:613\u2013619. doi: 10.1111\/1346-8138.12175","journal-title":"J Dermatol"},{"key":"8633_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/ijd.12243","volume":"54","author":"BJ Barrick","year":"2015","unstructured":"Barrick BJ, Lohse CM, Lehman JS (2015) Specific causes of death in patients with bullous pemphigoid as measured by death certificate data: a retrospective cohort study. Int J Dermatol 54:56\u201361. doi: 10.1111\/ijd.12243","journal-title":"Int J Dermatol"},{"key":"8633_CR25","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.0022-202X.2005.23628.x","volume":"124","author":"I Garcia-Doval","year":"2005","unstructured":"Garcia-Doval I, Conde Taboada A, Cruces Prado MJ (2005) Sepsis associated with dermatologic hospitalization is not the cause of high mortality of bullous pemphigoid in Europe. J Invest Dermatol 124:666\u2013667. doi: 10.1111\/j.0022-202X.2005.23628.x","journal-title":"J Invest Dermatol"},{"key":"8633_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jaad.2016.02.1153","volume":"75","author":"ES Robinson","year":"2016","unstructured":"Robinson ES, Payne AS, Pappas-Taffer L, Feng R, Werth VP (2016) The incidence of herpes zoster in cutaneous lupus erythematosus (CLE), dermatomyositis (DM), pemphigus vulgaris (PV), and bullous pemphigoid (BP). J Am Acad Dermatol 75:42\u201348. doi: 10.1016\/j.jaad.2016.02.1153","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1160\/th15-04-0309","volume":"115","author":"M Cugno","year":"2016","unstructured":"Cugno M, Marzano AV, Bucciarelli P, Balice Y, Cianchini G, Quaglino P, Calzavara Pinton P, Caproni M, Alaibac M, De Simone C, Patrizi A, Cozzani E, Papini M, Tedeschi A, Berti E, Rosendaal FR (2016) Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study. Thromb Haemost 115:193\u2013199. doi: 10.1160\/th15-04-0309","journal-title":"Thromb Haemost"},{"key":"8633_CR28","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","volume":"93","author":"JC Delgado","year":"1996","unstructured":"Delgado JC, Turbay D, Yunis EJ, Yunis JJ, Morton ED, Bhol K, Norman R, Alper CA, Good RA, Ahmed R (1996) A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A 93:8569\u20138571","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8633_CR29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2133.2001.04380.x","volume":"145","author":"J Setterfield","year":"2001","unstructured":"Setterfield J, Theron J, Vaughan RW, Welsh KI, Mallon E, Wojnarowska F, Challacombe SJ, Black MM (2001) Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. Br J Dermatol 145:406\u2013414","journal-title":"Br J Dermatol"},{"key":"8633_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.autrev.2011.07.002","volume":"11","author":"LR Zakka","year":"2011","unstructured":"Zakka LR, Reche P, Ahmed AR (2011) Role of MHC class II genes in the pathogenesis of pemphigoid. Autoimmun Rev 11:40\u201347. doi: 10.1016\/j.autrev.2011.07.002","journal-title":"Autoimmun Rev"},{"key":"8633_CR31","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1365-2133.1998.02350.x","volume":"138","author":"CC Banfield","year":"1998","unstructured":"Banfield CC, Wojnarowska F, Allen J, George S, Venning VA, Welsh KI (1998) The association of HLA-DQ7 with bullous pemphigoid is restricted to men. Br J Dermatol 138:1085\u20131090","journal-title":"Br J Dermatol"},{"key":"8633_CR32","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/nrg1489","volume":"5","author":"R Horton","year":"2004","unstructured":"Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC Jr, Wright MW, Wain HM, Trowsdale J, Ziegler A, Beck S (2004) Gene map of the extended human MHC. Nat Rev Genet 5:889\u2013899. doi: 10.1038\/nrg1489","journal-title":"Nat Rev Genet"},{"key":"8633_CR33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jama.284.3.350","volume":"284","author":"KB Yancey","year":"2000","unstructured":"Yancey KB, Egan CA (2000) Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations. JAMA 284:350\u2013356","journal-title":"JAMA"},{"key":"8633_CR34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/exd.12732","volume":"24","author":"M Hirose","year":"2015","unstructured":"Hirose M, Schilf P, Benoit S, Eming R, Glaser R, Homey B, Kunz M, Nebel A, Peitsch WK, Pfohler C, Sardy M, Schreiber S, Zillikens D, Schmidt E, Ibrahim SM (2015) Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population. Exp Dermatol 24:715\u2013717. doi: 10.1111\/exd.12732","journal-title":"Exp Dermatol"},{"key":"8633_CR35","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jamadermatol.2014.5263","volume":"151","author":"SC Cai","year":"2015","unstructured":"Cai SC, Allen JC, Lim YL, Tan SH, Tang MB (2015) Association of bullous pemphigoid and malignant neoplasms. JAMA Dermatol 151:665\u2013667. doi: 10.1001\/jamadermatol.2014.5263","journal-title":"JAMA Dermatol"},{"key":"8633_CR36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0738-081X(87)90050-2","volume":"5","author":"AL Schroeter","year":"1987","unstructured":"Schroeter AL (1987) Pemphigoid and malignancy. Clin Dermatol 5:60\u201363","journal-title":"Clin Dermatol"},{"key":"8633_CR37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2133.1990.tb01447.x","volume":"123","author":"VA Venning","year":"1990","unstructured":"Venning VA, Wojnarowska F (1990) The association of bullous pemphigoid and malignant disease: a case control study. Br J Dermatol 123:439\u2013445","journal-title":"Br J Dermatol"},{"key":"8633_CR38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archderm.1990.01670250072011","volume":"126","author":"B Lindelof","year":"1990","unstructured":"Lindelof B, Islam N, Eklund G, Arfors L (1990) Pemphigoid and cancer. Arch Dermatol 126:66\u201368","journal-title":"Arch Dermatol"},{"key":"8633_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00403-013-1399-5","volume":"306","author":"E Ong","year":"2014","unstructured":"Ong E, Goldacre R, Hoang U, Sinclair R, Goldacre M (2014) Associations between bullous pemphigoid and primary malignant cancers: an English national record linkage study, 1999-2011. Arch Dermatol Res 306:75\u201380. doi: 10.1007\/s00403-013-1399-5","journal-title":"Arch Dermatol Res"},{"key":"8633_CR40","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/jid.2014.547","volume":"135","author":"F Schulze","year":"2015","unstructured":"Schulze F, Neumann K, Recke A, Zillikens D, Linder R, Schmidt E (2015) Malignancies in pemphigus and pemphigoid diseases. J Invest Dermatol 135:1445\u20131447. doi: 10.1038\/jid.2014.547","journal-title":"J Invest Dermatol"},{"key":"8633_CR41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0923-1811(94)00371-K","volume":"9","author":"H Ogawa","year":"1995","unstructured":"Ogawa H, Sakuma M, Morioka S, Kitamura K, Sasai Y, Imamura S, Inaba Y (1995) The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan. J Dermatol Sci 9:136\u2013141","journal-title":"J Dermatol Sci"},{"key":"8633_CR42","doi-asserted-by":"publisher","unstructured":"Schmidt E, della Torre R, Borradori L (2012) Clinical features and practical diagnosis of bullous pemphigoid. Immunol Allergy Clin North Am 32:217\u2013232, v. 10.1016\/j.iac.2012.04.002","DOI":"10.1016\/j.iac.2012.04.002"},{"key":"8633_CR43","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1001\/jamadermatol.2014.51","volume":"150","author":"L Borradori","year":"2014","unstructured":"Borradori L, Joly P (2014) Toward a practical renaming of bullous pemphigoid and all its variants: cutaneous pemphigoid. JAMA Dermatol 150:459. doi: 10.1001\/jamadermatol.2014.51","journal-title":"JAMA Dermatol"},{"key":"8633_CR44","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/bjd.12936","volume":"171","author":"T Schmidt","year":"2014","unstructured":"Schmidt T, Sitaru C, Amber K, Hertl M (2014) BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid? Br J Dermatol 171:212\u2013219. doi: 10.1111\/bjd.12936","journal-title":"Br J Dermatol"},{"key":"8633_CR45","doi-asserted-by":"publisher","unstructured":"della Torre R, Combescure C, Cortes B, Marazza G, Beltraminelli H, Naldi L, Borradori L (2012) Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort. Br J Dermatol 167:1111\u20131117. 10.1111\/j.1365-2133.2012.11108.x","DOI":"10.1111\/j.1365-2133.2012.11108.x"},{"key":"8633_CR46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2340\/0001555561417421","volume":"61","author":"E Asbrink","year":"1981","unstructured":"Asbrink E, Hovmark A (1981) Clinical variations in bullous pemphigoid with respect to early symptoms. Acta Derm Venereol 61:417\u2013421","journal-title":"Acta Derm Venereol"},{"key":"8633_CR47","doi-asserted-by":"publisher","unstructured":"Amber KT, Korta DZ, de Feraudy S, Grando SA (2017) Vesiculobullous eruption in a patient receiving psoralen ultraviolet A (PUVA) treatment for prurigo nodules: a case of PUVA-aggravated pemphigoid nodularis. Clin Exp Dermatol. doi: 10.1111\/ced.13172","DOI":"10.1111\/ced.13172"},{"key":"8633_CR48","doi-asserted-by":"publisher","unstructured":"Hashimoto T, Ohzono A, Teye K, Numata S, Hiroyasu S, Tsuruta D, Hachiya T, Kuroda K, Hashiguchi M, Kawakami T, Ishii N (2016) Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid. Br J Dermatol. doi: 10.1111\/bjd.15114","DOI":"10.1111\/bjd.15114"},{"key":"8633_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clindermatol.2011.03.005","volume":"30","author":"G Zenzo Di","year":"2012","unstructured":"Di Zenzo G, Della Torre R, Zambruno G, Borradori L (2012) Bullous pemphigoid: from the clinic to the bench. Clin Dermatol 30:3\u201316. doi: 10.1016\/j.clindermatol.2011.03.005","journal-title":"Clin Dermatol"},{"key":"8633_CR50","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0190-9622(84)80441-7","volume":"10","author":"J Jawitz","year":"1984","unstructured":"Jawitz J, Kumar V, Nigra TP, Beutner EH (1984) Vesicular pemphigoid vs dermatitis herpetiformis. J Am Acad Dermatol 10:892\u2013896","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-0560.1989.tb00588.x","volume":"16","author":"HM Sander","year":"1989","unstructured":"Sander HM, Utz MM, Peters MS (1989) Bullous pemphigoid and dermatitis herpetiformis: mixed bullous disease or coexistence of two separate entities? J Cutan Pathol 16:370\u2013374","journal-title":"J Cutan Pathol"},{"key":"8633_CR52","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/archderm.1976.01630340020005","volume":"112","author":"SF Bean","year":"1976","unstructured":"Bean SF, Michel B, Furey N, Thorne G, Meltzer L (1976) Vesicular pemphigoid. Arch Dermatol 112:1402\u20131404","journal-title":"Arch Dermatol"},{"key":"8633_CR53","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1067\/S0190-9622(03)00515-2","volume":"49","author":"AS Geyer","year":"2003","unstructured":"Geyer AS, Zillikens D, Skrobek C, Cohen B, Anhalt GJ, Nousari HC (2003) Vesicular pemphigoid in a 16-year-old boy. J Am Acad Dermatol 49:722\u2013724","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000248430","volume":"178","author":"K Hayakawa","year":"1989","unstructured":"Hayakawa K, Shimizu H, Amagai M, Harada T, Nishikawa T, Yamasaki Y (1989) Vesicular pemphigoid\u2014ultrastructural and immunoelectron microscopic study. Dermatologica 178:213\u2013216","journal-title":"Dermatologica"},{"key":"8633_CR55","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0190-9622(80)80077-6","volume":"3","author":"GG Gruber","year":"1980","unstructured":"Gruber GG, Owen LG, Callen JP (1980) Vesicular pemphigoid. J Am Acad Dermatol 3:619\u2013622","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR56","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1046\/j.1365-2133.1998.02478.x","volume":"139","author":"Y Inoh","year":"1998","unstructured":"Inoh Y, Nishikawa T, Hashimoto T (1998) The vesicular pemphigoid phenotype may be related to antibodies to a 200 kDa antigen in the lower lamina lucida. Br J Dermatol 139:738\u2013739","journal-title":"Br J Dermatol"},{"key":"8633_CR57","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1365-4632.2012.05693.x","volume":"52","author":"I Zaraa","year":"2013","unstructured":"Zaraa I, Mahfoudh A, Sellami MK, Chelly I, El Euch D, Zitouna M, Mokni M, Makni S, Ben Osman A (2013) Lichen planus pemphigoides: four new cases and a review of the literature. Int J Dermatol 52:406\u2013412. doi: 10.1111\/j.1365-4632.2012.05693.x","journal-title":"Int J Dermatol"},{"key":"8633_CR58","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1525-1470.2009.00988.x","volume":"26","author":"DM Cohen","year":"2009","unstructured":"Cohen DM, Ben-Amitai D, Feinmesser M, Zvulunov A (2009) Childhood lichen planus pemphigoides: a case report and review of the literature. Pediatr Dermatol 26:569\u2013574. doi: 10.1111\/j.1525-1470.2009.00988.x","journal-title":"Pediatr Dermatol"},{"key":"8633_CR59","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0190-9622(98)70040-4","volume":"39","author":"P Joly","year":"1998","unstructured":"Joly P, Tanasescu S, Wolkenstein P, Bocquet H, Gilbert D, Thomine E, Wechsler J, Roujeau JC, Revuz J, Tron F, Lauret P (1998) Lichenoid erythrodermic bullous pemphigoid of the African patient. J Am Acad Dermatol 39:691\u2013697","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR60","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1365-2133.1995.tb06935.x","volume":"133","author":"NJ Korman","year":"1995","unstructured":"Korman NJ, Woods SG (1995) Erythrodermic bullous pemphigoid is a clinical variant of bullous pemphigoid. Br J Dermatol 133:967\u2013971","journal-title":"Br J Dermatol"},{"key":"8633_CR61","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0190-9622(82)80160-6","volume":"7","author":"D Wallach","year":"1982","unstructured":"Wallach D, Cottenot F (1982) Erythrodermic bullous pemphigoid or erythrodermic psoriasis and bullous pemphigoid? J Am Acad Dermatol 7:800","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR62","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0190-9622(98)70358-5","volume":"39","author":"J Alonso-Llamazares","year":"1998","unstructured":"Alonso-Llamazares J, Dietrich SM, Gibson LE (1998) Bullous pemphigoid presenting as exfoliative erythroderma. J Am Acad Dermatol 39:827\u2013830","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR63","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1600-0560.2008.01016.x","volume":"35","author":"J Kim","year":"2008","unstructured":"Kim J, Chavel S, Girardi M, McNiff JM (2008) Pemphigoid vegetans: a case report and review of the literature. J Cutan Pathol 35:1144\u20131147","journal-title":"J Cutan Pathol"},{"key":"8633_CR64","first-page":"331","volume":"28","author":"LS Chan","year":"1993","unstructured":"Chan LS, Dorman MA, Agha A, Suzuki T, Cooper KD, Hashimoto K (1993) Pemphigoid vegetans represents a bullous pemphigoid variant. Patient's IgG autoantibodies identify the major bullous pemphigoid antigen J Am Acad Dermatol 28:331\u2013335","journal-title":"Patient's IgG autoantibodies identify the major bullous pemphigoid antigen J Am Acad Dermatol"},{"key":"8633_CR65","first-page":"320","volume":"76","author":"MU Schnyder","year":"1969","unstructured":"Schnyder MU (1969) Seborrheic pemphigoid. A new nosologic entity? Bull Soc Fr Dermatol Syphiligr 76:320","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"8633_CR66","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jdcr.2015.12.010","volume":"2","author":"LL Castro-Fores","year":"2016","unstructured":"Castro-Fores LL, Cruz JM, Jamora MJ, Canlas-Estrella KM (2016) Seborrheic pemphigoid. JAAD Case Rep 2:80\u201383. doi: 10.1016\/j.jdcr.2015.12.010","journal-title":"JAAD Case Rep"},{"key":"8633_CR67","doi-asserted-by":"publisher","first-page":"768217","DOI":"10.1155\/2014\/768217","volume":"2014","author":"E Errichetti","year":"2014","unstructured":"Errichetti E, Stinco G (2014) Seborrheic pemphigoid 2014:768217. doi: 10.1155\/2014\/768217","journal-title":"Seborrheic pemphigoid"},{"key":"8633_CR68","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2133.2002.465611.x","volume":"146","author":"N Cordel","year":"2002","unstructured":"Cordel N, Courville P, Martel P, Musette P, Joly P (2002) Extensive erosive bullous pemphigoid: an atypical and serious clinical variant. Br J Dermatol 146:537\u2013539","journal-title":"Br J Dermatol"},{"key":"8633_CR69","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1097\/dad.0000000000000057","volume":"37","author":"M Marovt","year":"2015","unstructured":"Marovt M, El Shabrawi-Caelen L (2015) Purpuric bullous pemphigoid. Am J Dermatopathol 37:e18\u2013e20. doi: 10.1097\/dad.0000000000000057","journal-title":"Am J Dermatopathol"},{"key":"8633_CR70","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13023-014-0185-6","volume":"9","author":"A Schwieger-Briel","year":"2014","unstructured":"Schwieger-Briel A, Moellmann C, Mattulat B, Schauer F, Kiritsi D, Schmidt E, Sitaru C, Ott H, Kern JS (2014) Bullous pemphigoid in infants: characteristics, diagnosis and treatment. Orphanet J Rare Dis 9:185. doi: 10.1186\/s13023-014-0185-6","journal-title":"Orphanet J Rare Dis"},{"key":"8633_CR71","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s40520-015-0459-4","volume":"28","author":"P Pietkiewicz","year":"2016","unstructured":"Pietkiewicz P, Gornowicz-Porowska J, Bowszyc-Dmochowska M, Bartkiewicz P, Dmochowski M (2016) Bullous pemphigoid and neurodegenerative diseases: a study in a setting of a Central European university dermatology department. Aging Clin Exp Res 28:659\u2013663. doi: 10.1007\/s40520-015-0459-4","journal-title":"Aging Clin Exp Res"},{"key":"8633_CR72","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1365-2133.2011.10386.x","volume":"165","author":"YJ Chen","year":"2011","unstructured":"Chen YJ, Wu CY, Lin MW, Chen TJ, Liao KK, Chen YC, Hwang CY, Chu SY, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN (2011) Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study. Br J Dermatol 165:593\u2013599. doi: 10.1111\/j.1365-2133.2011.10386.x","journal-title":"Br J Dermatol"},{"key":"8633_CR73","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archderm.1987.01660270127031","volume":"123","author":"RJ Salomon","year":"1987","unstructured":"Salomon RJ, Briggaman RA, Wernikoff SY, Kayne AL (1987) Localized bullous pemphigoid. A mimic of acute contact dermatitis. Arch Dermatol 123:389\u2013392","journal-title":"Arch Dermatol"},{"key":"8633_CR74","doi-asserted-by":"publisher","first-page":"625","DOI":"10.4103\/0378-6323.84067","volume":"77","author":"A Batalla","year":"2011","unstructured":"Batalla A, Peon G, De la Torre C (2011) Localized bullous pemphigoid at urostomy site. Indian J Dermatol Venereol Leprol 77:625. doi: 10.4103\/0378-6323.84067","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"8633_CR75","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/00007611-199912000-00019","volume":"92","author":"CA Egan","year":"1999","unstructured":"Egan CA, Florell SR, Zone JJ (1999) Localized bullous pemphigoid in a patient with B-cell lymphoma. South Med J 92:1220\u20131222","journal-title":"South Med J"},{"key":"8633_CR76","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000362208","volume":"229","author":"T Nguyen","year":"2014","unstructured":"Nguyen T, Kwan JM, Ahmed AR (2014) Relationship between radiation therapy and bullous pemphigoid. Dermatology 229:88\u201396. doi: 10.1159\/000362208","journal-title":"Dermatology"},{"key":"8633_CR77","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.radonc.2006.11.014","volume":"82","author":"VE Mul","year":"2007","unstructured":"Mul VE, van Geest AJ, Pijls-Johannesma MC, Theys J, Verschueren TA, Jager JJ, Lambin P, Baumert BG (2007) Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effect. Radiother Oncol 82:5\u20139. doi: 10.1016\/j.radonc.2006.11.014","journal-title":"Radiother Oncol"},{"key":"8633_CR78","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1365-2230.2012.04402.x","volume":"37","author":"A Sears","year":"2012","unstructured":"Sears A, Wee JS, Misch K, Natkunarajah J (2012) Bullous pemphigoid induced by radiotherapy recurring on rechallenge. Clin Exp Dermatol 37:916\u2013917. doi: 10.1111\/j.1365-2230.2012.04402.x","journal-title":"Clin Exp Dermatol"},{"key":"8633_CR79","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1346-8138.2012.01562.x","volume":"39","author":"D Tsuruta","year":"2012","unstructured":"Tsuruta D, Nishikawa T, Yamagami J, Hashimoto T (2012) Unilateral bullous pemphigoid without erythema and eosinophil infiltration in a hemiplegic patient. J Dermatol 39:787\u2013789. doi: 10.1111\/j.1346-8138.2012.01562.x","journal-title":"J Dermatol"},{"key":"8633_CR80","first-page":"937","volume":"22","author":"YK Tay","year":"1993","unstructured":"Tay YK, Cheong WK (1993) An unusual case of localised pemphigoid. Ann Acad Med Singap 22:937\u2013938","journal-title":"Ann Acad Med Singap"},{"key":"8633_CR81","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2133.1993.tb03188.x","volume":"129","author":"CB Bunker","year":"1993","unstructured":"Bunker CB, Brown E (1993) Unilateral bullous pemphigoid in a hemiplegic patient. Br J Dermatol 129:502","journal-title":"Br J Dermatol"},{"key":"8633_CR82","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2133.1992.tb00110.x","volume":"126","author":"CC Long","year":"1992","unstructured":"Long CC, Lever LR, Marks R (1992) Unilateral bullous pemphigoid in a hemiplegic patient. Br J Dermatol 126:614\u2013616","journal-title":"Br J Dermatol"},{"key":"8633_CR83","first-page":"230","volume":"11","author":"N Foureur","year":"2001","unstructured":"Foureur N, Descamps V, Lebrun-Vignes B, Picard-Dahan C, Grossin M, Belaich S, Crickx B (2001) Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid? Eur J Dermatol 11:230\u2013233","journal-title":"Eur J Dermatol"},{"key":"8633_CR84","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/bmj.287.6396.875-a","volume":"287","author":"GD Reilly","year":"1983","unstructured":"Reilly GD, Boulton AJ, Harrington CI (1983) Stump pemphigoid: a new complication of the amputee. Br Med J (Clin Res Ed) 287:875\u2013876","journal-title":"Br Med J (Clin Res Ed)"},{"key":"8633_CR85","first-page":"245","volume":"57","author":"RT Brodell","year":"1996","unstructured":"Brodell RT, Korman NJ (1996) Stump pemphigoid. Cutis 57:245\u2013246","journal-title":"Cutis"},{"key":"8633_CR86","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-4362.1991.tb03898.x","volume":"30","author":"T Muramatsu","year":"1991","unstructured":"Muramatsu T, Iida T, Shirai T (1991) Antibasement membrane zone antibodies in localized pretibial pemphigoid. Int J Dermatol 30:422\u2013424","journal-title":"Int J Dermatol"},{"key":"8633_CR87","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0190-9622(92)70268-K","volume":"27","author":"L Borradori","year":"1992","unstructured":"Borradori L, Prost C, Wolkenstein P, Bernard P, Baccard M, Morel P (1992) Localized pretibial pemphigoid and pemphigoid nodularis. J Am Acad Dermatol 27:863\u2013867","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR88","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1365-2230.2007.02527.x","volume":"32","author":"M Kakurai","year":"2007","unstructured":"Kakurai M, Demitsu T, Azuma R, Yamada T, Suzuki M, Yoneda K, Ishii N, Hashimoto T (2007) Localized pemphigoid (pretibial type) with IgG antibody to BP180 NC16a domain successfully treated with minocycline and topical corticosteroid. Clin Exp Dermatol 32:759\u2013761. doi: 10.1111\/j.1365-2230.2007.02527.x","journal-title":"Clin Exp Dermatol"},{"key":"8633_CR89","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00000372-200306000-00001","volume":"25","author":"RE Fisler","year":"2003","unstructured":"Fisler RE, Saeb M, Liang MG, Howard RM, McKee PH (2003) Childhood bullous pemphigoid: a clinicopathologic study and review of the literature. Am J Dermatopathol 25:183\u2013189","journal-title":"Am J Dermatopathol"},{"key":"8633_CR90","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archderm.1992.01680160091011","volume":"128","author":"RW Saad","year":"1992","unstructured":"Saad RW, Domloge-Hultsch N, Yancey KB, Benson PM, James WD (1992) Childhood localized vulvar pemphigoid is a true variant of bullous pemphigoid. Arch Dermatol 128:807\u2013810","journal-title":"Arch Dermatol"},{"key":"8633_CR91","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1365-2133.1999.02668.x","volume":"140","author":"AM Farrell","year":"1999","unstructured":"Farrell AM, Kirtschig G, Dalziel KL, Allen J, Dootson G, Edwards S, Wojnarowska F (1999) Childhood vulval pemphigoid: a clinical and immunopathological study of five patients. Br J Dermatol 140:308\u2013312","journal-title":"Br J Dermatol"},{"key":"8633_CR92","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2340\/00015555-0644","volume":"89","author":"E Schmidt","year":"2009","unstructured":"Schmidt E, Benoit S, Brocker EB (2009) Bullous pemphigoid with localized umbilical involvement. Acta Derm Venereol 89:419\u2013420. doi: 10.2340\/00015555-0644","journal-title":"Acta Derm Venereol"},{"key":"8633_CR93","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/jdv.12995","volume":"29","author":"T Gambichler","year":"2015","unstructured":"Gambichler T, Segert H, Hoxtermann S, Schmitz L, Altmeyer P, Teegen B (2015) Neurological disorders in patients with bullous pemphigoid: clinical and experimental investigations. J Eur Acad Dermatol Venereol 29:1758\u20131762. doi: 10.1111\/jdv.12995","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8633_CR94","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1590\/abd1806-4841.20142516","volume":"89","author":"VB Teixeira","year":"2014","unstructured":"Teixeira VB, Cabral R, Brites MM, Vieira R, Figueiredo A (2014) Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients. An Bras Dermatol 89:274\u2013278","journal-title":"An Bras Dermatol"},{"key":"8633_CR95","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1684\/ejd.2010.0805","volume":"20","author":"H Jedlickova","year":"2010","unstructured":"Jedlickova H, Hlubinka M, Pavlik T, Semradova V, Budinska E, Vlasin Z (2010) Bullous pemphigoid and internal diseases\u2014a case-control study. Eur J Dermatol 20:96\u2013101. doi: 10.1684\/ejd.2010.0805","journal-title":"Eur J Dermatol"},{"key":"8633_CR96","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/archdermatol.2010.322","volume":"146","author":"K Taghipour","year":"2010","unstructured":"Taghipour K, Chi CC, Vincent A, Groves RW, Venning V, Wojnarowska F (2010) The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study. Arch Dermatol 146:1251\u20131254. doi: 10.1001\/archdermatol.2010.322","journal-title":"Arch Dermatol"},{"key":"8633_CR97","doi-asserted-by":"publisher","first-page":"37125","DOI":"10.1038\/srep37125","volume":"6","author":"AK Forsti","year":"2016","unstructured":"Forsti AK, Jokelainen J, Ansakorpi H, Seppanen A, Majamaa K, Timonen M, Tasanen K (2016) Psychiatric and neurological disorders are associated with bullous pemphigoid\u2014a nationwide Finnish Care Register study. Sci Rep 6:37125. doi: 10.1038\/srep37125","journal-title":"Sci Rep"},{"key":"8633_CR98","doi-asserted-by":"publisher","unstructured":"Lai YC, Yew YW, Lambert WC (2016) Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. doi: 10.1111\/jdv.13660","DOI":"10.1111\/jdv.13660"},{"key":"8633_CR99","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jaad.2014.07.052","volume":"71","author":"KE Brick","year":"2014","unstructured":"Brick KE, Weaver CH, Savica R, Lohse CM, Pittelkow MR, Boeve BF, Gibson LE, Camilleri MJ, Wieland CN (2014) A population-based study of the association between bullous pemphigoid and neurologic disorders. J Am Acad Dermatol 71:1191\u20131197. doi: 10.1016\/j.jaad.2014.07.052","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR100","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1590\/abd1806-4841.20153334","volume":"90","author":"MJ Tarazona","year":"2015","unstructured":"Tarazona MJ, Mota AN, Gripp AC, Unterstell N, Bressan AL (2015) Bullous pemphigoid and neurological disease: statistics from a dermatology service. An Bras Dermatol 90:280\u2013282. doi: 10.1590\/abd1806-4841.20153334","journal-title":"An Bras Dermatol"},{"key":"8633_CR101","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/jid.2010.357","volume":"131","author":"SM Langan","year":"2011","unstructured":"Langan SM, Groves RW, West J (2011) The relationship between neurological disease and bullous pemphigoid: a population-based case-control study. J Invest Dermatol 131:631\u2013636. doi: 10.1038\/jid.2010.357","journal-title":"J Invest Dermatol"},{"key":"8633_CR102","doi-asserted-by":"publisher","unstructured":"Daneshpazhooh M, Khorassani J, Balighi K, Ghandi N, Mahmoudi H, Tohidinik H, Hamzelou S, Chams-Davatchi C (2016) Neurological diseases and bullous pemphigoid: a case-control study in Iranian patients. Indian J Dermatol Venereol Leprol. 10.4103\/0378\u20136323.191132","DOI":"10.4103\/0378-6323.191132"},{"key":"8633_CR103","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/jid.2010.301","volume":"131","author":"S Bastuji-Garin","year":"2011","unstructured":"Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, Roujeau JC, Bernard P, Guillaume JC, Ingen-Housz-Oro S, Maillard H, Pauwels C, Picard-Dahan C, Dutronc Y, Richard MA (2011) Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol 131:637\u2013643. doi: 10.1038\/jid.2010.301","journal-title":"J Invest Dermatol"},{"key":"8633_CR104","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.annder.2015.12.016","volume":"143","author":"V Chevalier","year":"2016","unstructured":"Chevalier V, Barbe C, Reguiai Z, Plee J, Grange F, Bernard P (2016) Impact of neurological diseases on the prognosis of bullous pemphigoid: a retrospective study of 178 patients. Ann Dermatol Venereol 143:179\u2013186. doi: 10.1016\/j.annder.2015.12.016","journal-title":"Ann Dermatol Venereol"},{"key":"8633_CR105","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000106574","volume":"215","author":"N Cordel","year":"2007","unstructured":"Cordel N, Chosidow O, Hellot MF, Delaporte E, Lok C, Vaillant L, Bernard P, D'Incan M, Roujeau JC, Joly P (2007) Neurological disorders in patients with bullous pemphigoid. Dermatology 215:187\u2013191. doi: 10.1159\/000106574","journal-title":"Dermatology"},{"key":"8633_CR106","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.matbio.2005.11.004","volume":"25","author":"A Seppanen","year":"2006","unstructured":"Seppanen A, Autio-Harmainen H, Alafuzoff I, Sarkioja T, Veijola J, Hurskainen T, Bruckner-Tuderman L, Tasanen K, Majamaa K (2006) Collagen XVII is expressed in human CNS neurons. Matrix Biol 25:185\u2013188. doi: 10.1016\/j.matbio.2005.11.004","journal-title":"Matrix Biol"},{"key":"8633_CR107","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/cne.20549","volume":"487","author":"T Claudepierre","year":"2005","unstructured":"Claudepierre T, Manglapus MK, Marengi N, Radner S, Champliaud MF, Tasanen K, Bruckner-Tuderman L, Hunter DD, Brunken WJ (2005) Collagen XVII and BPAG1 expression in the retina: evidence for an anchoring complex in the central nervous system. J Comp Neurol 487:190\u2013203. doi: 10.1002\/cne.20549","journal-title":"J Comp Neurol"},{"key":"8633_CR108","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.brainres.2007.04.073","volume":"1158","author":"A Seppanen","year":"2007","unstructured":"Seppanen A, Suuronen T, Hofmann SC, Majamaa K, Alafuzoff I (2007) Distribution of collagen XVII in the human brain. Brain Res 1158:50\u201356. doi: 10.1016\/j.brainres.2007.04.073","journal-title":"Brain Res"},{"key":"8633_CR109","doi-asserted-by":"publisher","unstructured":"Amber KT, Zikry J, Hertl M (2017) A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading? Hla. 10.1111\/tan.12960","DOI":"10.1111\/tan.12960"},{"key":"8633_CR110","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jid.2015.12.005","volume":"136","author":"KA Messingham","year":"2016","unstructured":"Messingham KA, Aust S, Helfenberger J, Parker KL, Schultz S, McKillip J, Narayanan NS, Fairley JA (2016) Autoantibodies to collagen XVII are present in Parkinson's disease and localize to tyrosine-hydroxylase positive neurons. J Invest Dermatol 136:721\u2013723. doi: 10.1016\/j.jid.2015.12.005","journal-title":"J Invest Dermatol"},{"key":"8633_CR111","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/bjd.14538","volume":"175","author":"A Recke","year":"2016","unstructured":"Recke A, Oei A, Hubner F, Fechner K, Graf J, Hagenah J, May C, Woitalla D, Salmen A, Zillikens D, Gold R, Schlumberger W, Schmidt E (2016) Parkinson disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction. Br J Dermatol 175:407\u2013409. doi: 10.1111\/bjd.14538","journal-title":"Br J Dermatol"},{"key":"8633_CR112","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/ng.3395","volume":"47","author":"L Moutsianas","year":"2015","unstructured":"Moutsianas L, Jostins L, Beecham AH et al (2015) Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat Genet 47:1107\u20131113. doi: 10.1038\/ng.3395","journal-title":"Nat Genet"},{"key":"8633_CR113","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1212\/WNL.51.3.742","volume":"51","author":"BG Weinshenker","year":"1998","unstructured":"Weinshenker BG, Santrach P, Bissonet AS, McDonnell SK, Schaid D, Moore SB, Rodriguez M (1998) Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology 51:742\u2013747","journal-title":"Neurology"},{"key":"8633_CR114","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/hmg\/7.8.1235","volume":"7","author":"MG Marrosu","year":"1998","unstructured":"Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F (1998) DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 7:1235\u20131237","journal-title":"Hum Mol Genet"},{"key":"8633_CR115","doi-asserted-by":"publisher","unstructured":"Fernandez O, A RA, Pinto-Medel MJ, Mendibe MM, Acosta N, Oliver B, Guerrero M, Papais-Alvarenga M, Fernandez-Sanchez V, Leyva L (2009) HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J Neurol 256:1977\u20131988. 10.1007\/s00415-009-5223-2","DOI":"10.1007\/s00415-009-5223-2"},{"key":"8633_CR116","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1191\/1352458504ms1065oa","volume":"10","author":"S Al-Shammri","year":"2004","unstructured":"Al-Shammri S, Nelson RF, Al-Muzairi I, Akanji AO (2004) HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population. Mult Scler 10:381\u2013386","journal-title":"Mult Scler"},{"key":"8633_CR117","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3346\/jkms.2004.19.3.426","volume":"19","author":"HH Oh","year":"2004","unstructured":"Oh HH, Kwon SH, Kim CW, Choe BH, Ko CW, Jung HD, Suh JS, Lee JH (2004) Molecular analysis of HLA class II-associated susceptibility to neuroinflammatory diseases in Korean children. J Korean Med Sci 19:426\u2013430. doi: 10.3346\/jkms.2004.19.3.426","journal-title":"J Korean Med Sci"},{"key":"8633_CR118","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1590\/abd1806-4841.20164935","volume":"91","author":"A Kouris","year":"2016","unstructured":"Kouris A, Platsidaki E, Christodoulou C, Armyra K, Korkoliakou P, Stefanaki C, Tsatovidou R, Rigopoulos D, Kontochristopoulos G (2016) Quality of life, depression, anxiety and loneliness in patients with bullous pemphigoid. A case control study. An Bras Dermatol 91:601\u2013603. doi: 10.1590\/abd1806-4841.20164935","journal-title":"An Bras Dermatol"},{"key":"8633_CR119","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/2013.jamadermatol.376","volume":"149","author":"A Lloyd-Lavery","year":"2013","unstructured":"Lloyd-Lavery A, Chi CC, Wojnarowska F, Taghipour K (2013) The associations between bullous pemphigoid and drug use: a UK case-control study. JAMA Dermatol 149:58\u201362. doi: 10.1001\/2013.jamadermatol.376","journal-title":"JAMA Dermatol"},{"key":"8633_CR120","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.1996.03890270044006","volume":"132","author":"S Bastuji-Garin","year":"1996","unstructured":"Bastuji-Garin S, Joly P, Picard-Dahan C, Bernard P, Vaillant L, Pauwels C, Salagnac V, Lok C, Roujeau JC (1996) Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol 132:272\u2013276","journal-title":"Arch Dermatol"},{"key":"8633_CR121","doi-asserted-by":"publisher","unstructured":"CW XT, Pang Y, Sim B, Thirumoorthy T, Pang SM, Lee HY (2016) The association between drugs and bullous pemphigoid. Br J Dermatol 10.1111\/bjd.15195","DOI":"10.1111\/bjd.15195"},{"key":"8633_CR122","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/bjd.14601","volume":"175","author":"J Bene","year":"2016","unstructured":"Bene J, Moulis G, Bennani I, Auffret M, Coupe P, Babai S, Hillaire-Buys D, Micallef J, Gautier S (2016) Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French pharmacovigilance database. Br J Dermatol 175:296\u2013301. doi: 10.1111\/bjd.14601","journal-title":"Br J Dermatol"},{"key":"8633_CR123","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1158\/2326-6066.cir-15-0123","volume":"4","author":"J Naidoo","year":"2016","unstructured":"Naidoo J, Schindler K, Querfeld C, Busam K, Cunningham J, Page DB, Postow MA, Weinstein A, Lucas AS, Ciccolini KT, Quigley EA, Lesokhin AM, Paik PK, Chaft JE, Segal NH, D'Angelo SP, Dickson MA, Wolchok JD, Lacouture ME (2016) Autoimmune bullous skin disorders with immune checkpoint inhibitors targeting PD-1 and PD-L1. Cancer Immunol Res 4:383\u2013389. doi: 10.1158\/2326-6066.cir-15-0123","journal-title":"Cancer Immunol Res"},{"key":"8633_CR124","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/cup.12717","volume":"43","author":"G Jour","year":"2016","unstructured":"Jour G, Glitza IC, Ellis RM, Torres-Cabala CA, Tetzlaff MT, Li JY, Nagarajan P, Huen A, Aung PP, Ivan D, Drucker CR, Prieto VG, Rapini RP, Patel A, Curry JL (2016) Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions. J Cutan Pathol 43:688\u2013696. doi: 10.1111\/cup.12717","journal-title":"J Cutan Pathol"},{"key":"8633_CR125","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/cup.12735","volume":"43","author":"MC Mochel","year":"2016","unstructured":"Mochel MC, Ming ME, Imadojemu S, Gangadhar TC, Schuchter LM, Elenitsas R, Payne AS, Chu EY (2016) Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma. J Cutan Pathol 43:787\u2013791. doi: 10.1111\/cup.12735","journal-title":"J Cutan Pathol"},{"key":"8633_CR126","doi-asserted-by":"publisher","unstructured":"Amber KT, Panganiban CM, Korta D, Feraudy S, Kelly KM, Grando SA (2016) A case report of bullous pemphigoid associated with a melanoma and review of the literature. Melanoma Res. doi: 10.1097\/cmr.0000000000000307","DOI":"10.1097\/cmr.0000000000000307"},{"key":"8633_CR127","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2133.1978.tb07067.x","volume":"99","author":"JK Robinson","year":"1978","unstructured":"Robinson JK, Baughman RD, Provost TT (1978) Bullous pemphigoid induced by PUVA therapy. Is this the aetiology of the acral bullae produced during PUVA treatment? Br J Dermatol 99:709\u2013713","journal-title":"Br J Dermatol"},{"key":"8633_CR128","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0781.1995.tb00166.x","volume":"11","author":"PM George","year":"1996","unstructured":"George PM (1996) Bullous pemphigoid possibly induced by psoralen plus ultraviolet a therapy. Photodermatol Photoimmunol Photomed 11:185\u2013187","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"8633_CR129","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1365-4632.2004.02517.x","volume":"45","author":"MA Barnadas","year":"2006","unstructured":"Barnadas MA, Gilaberte M, Pujol R, Agusti M, Gelpi C, Alomar A (2006) Bullous pemphigoid in a patient with psoriasis during the course of PUVA therapy: study by ELISA test. Int J Dermatol 45:1089\u20131092. doi: 10.1111\/j.1365-4632.2004.02517.x","journal-title":"Int J Dermatol"},{"key":"8633_CR130","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4103\/0378-6323.136936","volume":"80","author":"N Riyaz","year":"2014","unstructured":"Riyaz N, Nasir N, Bindu V, Sasidharanpillai S (2014) Bullous pemphigoid induced by topical PUVASOL. Indian J Dermatol Venereol Leprol 80:363\u2013364. doi: 10.4103\/0378-6323.136936","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"8633_CR131","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2133.2000.03366.x","volume":"142","author":"N Kuramoto","year":"2000","unstructured":"Kuramoto N, Kishimoto S, Shibagaki R, Yasuno H (2000) PUVA-induced lichen planus pemphigoides. Br J Dermatol 142:509\u2013512","journal-title":"Br J Dermatol"},{"key":"8633_CR132","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaad.2015.03.016","volume":"73","author":"C Ohata","year":"2015","unstructured":"Ohata C, Ishii N, Koga H, Fukuda S, Tateishi C, Tsuruta D, Furumura M, Hashimoto T (2015) Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: a series of 145 cases. J Am Acad Dermatol 73:50\u201355. doi: 10.1016\/j.jaad.2015.03.016","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR133","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2133.1996.tb03883.x","volume":"135","author":"G Kirtschig","year":"1996","unstructured":"Kirtschig G, Chow ET, Venning VA, Wojnarowska FT (1996) Acquired subepidermal bullous diseases associated with psoriasis: a clinical, immunopathological and immunogenetic study. Br J Dermatol 135:738\u2013745","journal-title":"Br J Dermatol"},{"key":"8633_CR134","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/jdv.12132","volume":"28","author":"SD Chung","year":"2014","unstructured":"Chung SD, Lin HC, Wang KH (2014) Increased risk of pemphigoid following scabies: a population-based matched-cohort study. J Eur Acad Dermatol Venereol 28:558\u2013564. doi: 10.1111\/jdv.12132","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8633_CR135","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/jid.2008.412","volume":"129","author":"P Joly","year":"2009","unstructured":"Joly P, Roujeau JC, Benichou J et al (2009) A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol 129:1681\u20131687. doi: 10.1038\/jid.2008.412","journal-title":"J Invest Dermatol"},{"key":"8633_CR136","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa011592","volume":"346","author":"P Joly","year":"2002","unstructured":"Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, Vaillant L, D'Incan M, Plantin P, Bedane C, Young P, Bernard P (2002) A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 346:321\u2013327. doi: 10.1056\/NEJMoa011592","journal-title":"N Engl J Med"},{"key":"8633_CR137","doi-asserted-by":"publisher","unstructured":"Schneiderbauer R, Martinache S, Engstner M, Enk AH, Hadaschik EN (2016) Correlation of autoantibodies against BP180\/BP230 in response to topical corticosteroids in patients with bullous pemphigoid. Dermatol Ther. doi: 10.1111\/dth.12403","DOI":"10.1111\/dth.12403"},{"key":"8633_CR138","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/ddg.12606","volume":"13","author":"R Eming","year":"2015","unstructured":"Eming R, Sticherling M, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Pfeiffer C, Schuster V, Zillikens D, Goebeler M, Hertl M, Nast A, Orzechowski HD, Sardy M, Schmidt E, Sitaru C, Sporbeck B, Worm M (2015) S2k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges 13:833\u2013844. doi: 10.1111\/ddg.12606","journal-title":"J Dtsch Dermatol Ges"},{"key":"8633_CR139","first-page":"327","volume":"41","author":"AT Goon","year":"2000","unstructured":"Goon AT, Tan SH, Khoo LS, Tan T (2000) Tetracycline and nicotinamide for the treatment of bullous pemphigoid: our experience in Singapore. Singap Med J 41:327\u2013330","journal-title":"Singap Med J"},{"key":"8633_CR140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0190-9622(97)70336-0","volume":"36","author":"B Hornschuh","year":"1997","unstructured":"Hornschuh B, Hamm H, Wever S, Hashimoto T, Schroder U, Brocker EB, Zillikens D (1997) Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol. J Am Acad Dermatol 36:101\u2013103","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR141","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","volume":"130","author":"DP Fivenson","year":"1994","unstructured":"Fivenson DP, Breneman DL, Rosen GB, Hersh CS, Cardone S, Mutasim D (1994) Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol 130:753\u2013758","journal-title":"Arch Dermatol"},{"key":"8633_CR142","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0190-9622(93)70013-J","volume":"28","author":"I Thomas","year":"1993","unstructured":"Thomas I, Khorenian S, Arbesfeld DM (1993) Treatment of generalized bullous pemphigoid with oral tetracycline. J Am Acad Dermatol 28:74\u201377","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR143","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2133.1995.tb02498.x","volume":"133","author":"DN Kolbach","year":"1995","unstructured":"Kolbach DN, Remme JJ, Bos WH, Jonkman MF, De Jong MC, Pas HH, van der Meer JB (1995) Bullous pemphigoid successfully controlled by tetracycline and nicotinamide. Br J Dermatol 133:88\u201390","journal-title":"Br J Dermatol"},{"key":"8633_CR144","doi-asserted-by":"publisher","unstructured":"Williams HC, Wojnarowska F, Kirtschig G, Mason J, Godec TR, Schmidt E, Chalmers JR, Childs M, Walton S, Harman K, Chapman A, Whitham D, Nunn AJ (2017) Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial. Lancet. doi: 10.1016\/s0140-6736(17)30560-3","DOI":"10.1016\/s0140-6736(17)30560-3"},{"key":"8633_CR145","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaad.2007.08.010","volume":"58","author":"O Waisbourd-Zinman","year":"2008","unstructured":"Waisbourd-Zinman O, Ben-Amitai D, Cohen AD, Feinmesser M, Mimouni D, Adir-Shani A, Zlotkin M, Zvulunov A (2008) Bullous pemphigoid in infancy: clinical and epidemiologic characteristics. J Am Acad Dermatol 58:41\u201348. doi: 10.1016\/j.jaad.2007.08.010","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR146","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/bjd.13633","volume":"173","author":"YT Cho","year":"2015","unstructured":"Cho YT, Chu CY, Wang LF (2015) First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid. Br J Dermatol 173:302\u2013304. doi: 10.1111\/bjd.13633","journal-title":"Br J Dermatol"},{"key":"8633_CR147","first-page":"672","volume":"12","author":"S Shetty","year":"2013","unstructured":"Shetty S, Ahmed AR (2013) Treatment of bullous pemphigoid with rituximab: critical analysis of the current literature. J Drugs Dermatol 12:672\u2013677","journal-title":"J Drugs Dermatol"},{"issue":"700\u2013708","key":"8633_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.11.030","volume":"74","author":"AR Ahmed","year":"2016","unstructured":"Ahmed AR, Shetty S, Kaveri S, Spigelman ZS (2016) Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: a retrospective study with a 6-year follow-up. J Am Acad Dermatol 74(700\u2013708):e703. doi: 10.1016\/j.jaad.2015.11.030","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR149","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1067\/mjd.2001.116337","volume":"45","author":"AR Ahmed","year":"2001","unstructured":"Ahmed AR (2001) Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol 45:825\u2013835. doi: 10.1067\/mjd.2001.116337","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR150","doi-asserted-by":"publisher","unstructured":"Amagai M, Ikeda S, Hashimoto T et al (2016) A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid. J Dermatol Sci. doi: 10.1016\/j.jdermsci.2016.11.003","DOI":"10.1016\/j.jdermsci.2016.11.003"},{"key":"8633_CR151","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/pde.12635","volume":"32","author":"B Tekin","year":"2015","unstructured":"Tekin B, Yucelten AD (2015) Infantile bullous pemphigoid treated using intravenous immunoglobulin: case report and review of the literature. Pediatr Dermatol 32:723\u2013726. doi: 10.1111\/pde.12635","journal-title":"Pediatr Dermatol"},{"key":"8633_CR152","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1345\/aph.1K198","volume":"41","author":"HM Gurcan","year":"2007","unstructured":"Gurcan HM, Ahmed AR (2007) Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid. Ann Pharmacother 41:1604\u20131610. doi: 10.1345\/aph.1K198","journal-title":"Ann Pharmacother"},{"key":"8633_CR153","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamadermatol.2016.3357","volume":"153","author":"N Beek van","year":"2017","unstructured":"van Beek N, Luttmann N, Huebner F, Recke A, Karl I, Schulze FS, Zillikens D, Schmidt E (2017) Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity. JAMA Dermatol 153:30\u201338. doi: 10.1001\/jamadermatol.2016.3357","journal-title":"JAMA Dermatol"},{"key":"8633_CR154","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jaad.2014.04.053","volume":"71","author":"KK Yu","year":"2014","unstructured":"Yu KK, Crew AB, Messingham KA, Fairley JA, Woodley DT (2014) Omalizumab therapy for bullous pemphigoid. J Am Acad Dermatol 71:468\u2013474. doi: 10.1016\/j.jaad.2014.04.053","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR155","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1111\/jdv.13758","volume":"30","author":"G Balakirski","year":"2016","unstructured":"Balakirski G, Alkhateeb A, Merk HF, Leverkus M, Megahed M (2016) Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature. J Eur Acad Dermatol Venereol 30:1778\u20131782. doi: 10.1111\/jdv.13758","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8633_CR156","first-page":"523","volume":"60","author":"AD Yalcin","year":"2014","unstructured":"Yalcin AD, Genc GE, Celik B, Gumuslu S (2014) Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and its effects on soluble CD200. Clin Lab 60:523\u2013524","journal-title":"Clin Lab"},{"key":"8633_CR157","doi-asserted-by":"publisher","unstructured":"Gonul MZ, Keseroglu HO, Ergin C, Ozcan I, Erdem O (2016) Bullous pemphigoid successfully treated with omalizumab. Indian J Dermatol Venereol Leprol 82:577\u2013579. 10.4103\/0378\u20136323.183628","DOI":"10.4103\/0378-6323.183628"},{"key":"8633_CR158","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00403-015-1606-7","volume":"308","author":"M Mersmann","year":"2016","unstructured":"Mersmann M, Dworschak J, Ebermann K, Komorowski L, Schlumberger W, Stocker W, Zillikens D, Probst C, Schmidt E (2016) Immunoadsorber for specific apheresis of autoantibodies in the treatment of bullous pemphigoid. Arch Dermatol Res 308:31\u201338. doi: 10.1007\/s00403-015-1606-7","journal-title":"Arch Dermatol Res"},{"key":"8633_CR159","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.jaad.2014.06.014","volume":"71","author":"M Kasperkiewicz","year":"2014","unstructured":"Kasperkiewicz M, Schulze F, Meier M, van Beek N, Nitschke M, Zillikens D, Schmidt E (2014) Treatment of bullous pemphigoid with adjuvant immunoadsorption: a case series. J Am Acad Dermatol 71:1018\u20131020. doi: 10.1016\/j.jaad.2014.06.014","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR160","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/jdv.12175","volume":"28","author":"M Kolesnik","year":"2014","unstructured":"Kolesnik M, Becker E, Reinhold D, Ambach A, Heim MU, Gollnick H, Bonnekoh B (2014) Treatment of severe autoimmune blistering skin diseases with combination of protein a immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication. J Eur Acad Dermatol Venereol 28:771\u2013780. doi: 10.1111\/jdv.12175","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8633_CR161","doi-asserted-by":"publisher","unstructured":"de Graauw E, Sitaru C, Horn M, Borradori L, Yousefi S, Simon HU, Simon D (2017) Evidence for a role of eosinophils in blister formation in bullous pemphigoid. Allergy. doi: 10.1111\/all.13131","DOI":"10.1111\/all.13131"},{"key":"8633_CR162","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.clindermatol.2011.03.009","volume":"30","author":"J Lipozencic","year":"2012","unstructured":"Lipozencic J, Ljubojevic S, Bukvic-Mokos Z (2012) Pemphigoid gestationis. Clin Dermatol 30:51\u201355. doi: 10.1016\/j.clindermatol.2011.03.009","journal-title":"Clin Dermatol"},{"key":"8633_CR163","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0190-9622(83)70027-7","volume":"8","author":"JK Shornick","year":"1983","unstructured":"Shornick JK, Bangert JL, Freeman RG, Gilliam JN (1983) Herpes gestationis: clinical and histologic features of twenty-eight cases. J Am Acad Dermatol 8:214\u2013224","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR164","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejogrb.2009.05.012","volume":"145","author":"K Semkova","year":"2009","unstructured":"Semkova K, Black M (2009) Pemphigoid gestationis: current insights into pathogenesis and treatment. Eur J Obstet Gynecol Reprod Biol 145:138\u2013144. doi: 10.1016\/j.ejogrb.2009.05.012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"8633_CR165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2230.1995.tb02668.x","volume":"20","author":"JK Shornick","year":"1995","unstructured":"Shornick JK, Jenkins RE, Artlett CM, Briggs DC, Welsh KI, Kelly SE, Garvey MP, Black MM (1995) Class II MHC typing in pemphigoid gestationis. Clin Exp Dermatol 20:123\u2013126","journal-title":"Clin Exp Dermatol"},{"key":"8633_CR166","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2230.1999.00472.x","volume":"24","author":"RE Jenkins","year":"1999","unstructured":"Jenkins RE, Hern S, Black MM (1999) Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol 24:255\u2013259","journal-title":"Clin Exp Dermatol"},{"key":"8633_CR167","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2133.1983.tb07073.x","volume":"109","author":"RC Holmes","year":"1983","unstructured":"Holmes RC, Black MM, Jurecka W, Dann J, James DC, Timlin D, Bhogal B (1983) Clues to the aetiology and pathogenesis of herpes gestationis. Br J Dermatol 109:131\u2013139","journal-title":"Br J Dermatol"},{"key":"8633_CR168","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jri.2016.04.286","volume":"116","author":"F Al-Saif","year":"2016","unstructured":"Al-Saif F, Elisa A, Al-Homidy A, Al-Ageel A, Al-Mubarak M (2016) Retrospective analysis of pemphigoid gestationis in 32 Saudi patients\u2014clinicopathological features and a literature review. J Reprod Immunol 116:42\u201345. doi: 10.1016\/j.jri.2016.04.286","journal-title":"J Reprod Immunol"},{"key":"8633_CR169","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/bjd.13374","volume":"172","author":"N Tani","year":"2015","unstructured":"Tani N, Kimura Y, Koga H, Kawakami T, Ohata C, Ishii N, Hashimoto T (2015) Clinical and immunological profiles of 25 patients with pemphigoid gestationis. Br J Dermatol 172:120\u2013129. doi: 10.1111\/bjd.13374","journal-title":"Br J Dermatol"},{"key":"8633_CR170","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/archderm.1994.01690060064006","volume":"130","author":"D Roger","year":"1994","unstructured":"Roger D, Vaillant L, Fignon A, Pierre F, Bacq Y, Brechot JF, Grangeponte MC, Lorette G (1994) Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women. Arch Dermatol 130:734\u2013739","journal-title":"Arch Dermatol"},{"key":"8633_CR171","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2133.1996.tb03838.x","volume":"135","author":"RE Jenkins","year":"1996","unstructured":"Jenkins RE, Jones SA, Black MM (1996) Conversion of pemphigoid gestationis to bullous pemphigoid\u2014two refractory cases highlighting this association. Br J Dermatol 135:595\u2013598","journal-title":"Br J Dermatol"},{"key":"8633_CR172","doi-asserted-by":"publisher","unstructured":"Chi CC, Wang SH, Wojnarowska F, Kirtschig G, Davies E, Bennett C (2015) Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev:Cd007346. 10.1002\/14651858.CD007346.pub3","DOI":"10.1002\/14651858.CD007346.pub3"},{"key":"8633_CR173","doi-asserted-by":"publisher","unstructured":"Gotestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, da Silva J (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. 75:795-810. 10.1136\/annrheumdis-2015-208840","DOI":"10.1136\/annrheumdis-2015-208840"},{"key":"8633_CR174","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2265.1997.1230939.x","volume":"46","author":"R Benediktsson","year":"1997","unstructured":"Benediktsson R, Calder AA, Edwards CR, Seckl JR (1997) Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol 46:161\u2013166","journal-title":"Clin Endocrinol"},{"key":"8633_CR175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2310\/7750.2009.09001","volume":"14","author":"P Doiron","year":"2010","unstructured":"Doiron P, Pratt M (2010) Antepartum intravenous immunoglobulin therapy in refractory pemphigoid gestationis: case report and literature review. J Cutan Med Surg 14:189\u2013192","journal-title":"J Cutan Med Surg"},{"key":"8633_CR176","doi-asserted-by":"publisher","unstructured":"Tourte M, Brunet-Possenti F, Mignot S, Gavard L, Descamps V (2016) Pemphigoid gestationis: a successful preventive treatment by rituximab. J Eur Acad Dermatol Venereol. doi: 10.1111\/jdv.13962","DOI":"10.1111\/jdv.13962"},{"key":"8633_CR177","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","volume":"117","author":"EF Chakravarty","year":"2011","unstructured":"Chakravarty EF, Murray ER, Kelman A, Farmer P (2011) Pregnancy outcomes after maternal exposure to rituximab. Blood 117:1499\u20131506. doi: 10.1182\/blood-2010-07-295444","journal-title":"Blood"},{"key":"8633_CR178","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/1523-1747.ep12349283","volume":"106","author":"D Zillikens","year":"1996","unstructured":"Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank CV, Liu Z, Giudice GJ, Tran HH, Marinkovich MP, Brocker EB, Hashimoto T (1996) A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 106:1333\u20131338","journal-title":"J Invest Dermatol"},{"key":"8633_CR179","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2133.1996.tb07625.x","volume":"134","author":"KR Chen","year":"1996","unstructured":"Chen KR, Shimizu S, Miyakawa S, Ishiko A, Shimizu H, Hashimoto T (1996) Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen. Br J Dermatol 134:340\u2013346","journal-title":"Br J Dermatol"},{"key":"8633_CR180","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1073\/pnas.0809230106","volume":"106","author":"T Dainichi","year":"2009","unstructured":"Dainichi T, Kurono S, Ohyama B, Ishii N, Sanzen N, Hayashi M, Shimono C, Taniguchi Y, Koga H, Karashima T, Yasumoto S, Zillikens D, Sekiguchi K, Hashimoto T (2009) Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci U S A 106:2800\u20132805","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8633_CR181","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2133.2010.10056.x","volume":"164","author":"S Groth","year":"2011","unstructured":"Groth S, Recke A, Vafia K, Ludwig RJ, Hashimoto T, Zillikens D, Schmidt E (2011) Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid. Br J Dermatol 164:76\u201382. doi: 10.1111\/j.1365-2133.2010.10056.x","journal-title":"Br J Dermatol"},{"key":"8633_CR182","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1346-8138.2009.00793.x","volume":"37","author":"T Dainichi","year":"2010","unstructured":"Dainichi T, Koga H, Tsuji T, Ishii N, Ohyama B, Ueda A, Natsuaki Y, Karashima T, Nakama T, Yasumoto S, Zillikens D, Hashimoto T (2010) From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid. J Dermatol 37:231\u2013238","journal-title":"J Dermatol"},{"key":"8633_CR183","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jaad.2014.02.036","volume":"71","author":"S Goletz","year":"2014","unstructured":"Goletz S, Hashimoto T, Zillikens D, Schmidt E (2014) Anti-p200 pemphigoid. J Am Acad Dermatol 71:185\u2013191. doi: 10.1016\/j.jaad.2014.02.036","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR184","first-page":"1","volume":"50","author":"E Schmidt","year":"2016","unstructured":"Schmidt E, Groves R (2016) Immunobullous diseases. In: Griffith C, Barker J, Chalmers, Bleiker T, Creamer D (Eds) Rook's Textbook of Dermatology, part 3, chapter 50, 9th edition Wiley. Chichester 50:1\u201356","journal-title":"Chichester"},{"key":"8633_CR185","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/ced.12823","volume":"41","author":"S Geller","year":"2016","unstructured":"Geller S, Gat A, Zeeli T, Schmidt E, Ishii N, Hashimoto T, Zillikens D, Sprecher E (2016) A refractory, cutaneous, subepidermal bullous disease. Clin Exp Dermatol 41:573\u2013575. doi: 10.1111\/ced.12823","journal-title":"Clin Exp Dermatol"},{"key":"8633_CR186","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0190-9622(00)90101-4","volume":"42","author":"JM Mascaro Jr","year":"2000","unstructured":"Mascaro JM Jr, Zillikens D, Giudice GJ, Caux F, Fleming MG, Katz HM, Diaz LA (2000) A subepidermal bullous eruption associated with IgG autoantibodies to a 200 kd dermal antigen: the first case report from the United States. J Am Acad Dermatol 42:309\u2013315","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR187","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/bjd.14629","volume":"175","author":"MH Commin","year":"2016","unstructured":"Commin MH, Schmidt E, Duvert-Lehembre S, Lasek A, Morice C, Estival JL, Debarbieux S, Rigal E, Pauwels C, De Quatrebarbes J, Roussel A, Goujon E, Stoebner PE, Jouen F, Joly P (2016) Clinical and immunological features and outcome of anti-p200 pemphigoid. Br J Dermatol 175:776\u2013781. doi: 10.1111\/bjd.14629","journal-title":"Br J Dermatol"},{"key":"8633_CR188","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/jamadermatol.2016.1099","volume":"152","author":"JM Meijer","year":"2016","unstructured":"Meijer JM, Diercks GF, Schmidt E, Pas HH, Jonkman MF (2016) Laboratory diagnosis and clinical profile of anti-p200 pemphigoid. JAMA Dermatol 152:897\u2013904. doi: 10.1001\/jamadermatol.2016.1099","journal-title":"JAMA Dermatol"},{"key":"8633_CR189","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1365-2133.2012.11076.x","volume":"167","author":"B Monshi","year":"2012","unstructured":"Monshi B, Groth S, Richter L, Schmidt E, Zillikens D, Rappersberger K (2012) A long-term study of a patient with anti-p200 pemphigoid: correlation of autoantibody levels with disease activity and an example of epitope spreading. Br J Dermatol 167:1179\u20131183. doi: 10.1111\/j.1365-2133.2012.11076.x","journal-title":"Br J Dermatol"},{"key":"8633_CR190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1346-8138.2007.00208.x","volume":"34","author":"A Dilling","year":"2007","unstructured":"Dilling A, Rose C, Hashimoto T, Zillikens D, Shimanovich I (2007) Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease. J Dermatol 34:1\u20138","journal-title":"J Dermatol"},{"key":"8633_CR191","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1365-2133.2007.07810.x","volume":"156","author":"N Yamane","year":"2007","unstructured":"Yamane N, Sawamura D, Nishie W, Abe M, Kodama K, Adachi K, Nakamura H, Ishii N, Hashimoto T, Shimizu H (2007) Anti-p200 pemphigoid in a 17-year-old girl successfully treated with systemic corticosteroid and dapsone. Br J Dermatol 156:1075\u20131078. doi: 10.1111\/j.1365-2133.2007.07810.x","journal-title":"Br J Dermatol"},{"key":"8633_CR192","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1365-2230.2009.03731.x","volume":"35","author":"M Kasperkiewicz","year":"2010","unstructured":"Kasperkiewicz M, Hoppe U, Zillikens D, Schmidt E (2010) Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid. Clin Exp Dermatol 35:614\u2013617. doi: 10.1111\/j.1365-2230.2009.03731.x","journal-title":"Clin Exp Dermatol"},{"key":"8633_CR193","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/bjd.12033","volume":"168","author":"A Shimizu","year":"2013","unstructured":"Shimizu A, Funakoshi T, Ishibashi M, Yoshida T, Koga H, Hashimoto T, Amagai M, Ishiko A (2013) Immunoglobulin G deposition to nonhemidesmosomal lamina lucida and early neutrophil involvement are characteristic features in a case of anti-p200 pemphigoid. Br J Dermatol 168:647\u2013655. doi: 10.1111\/bjd.12033","journal-title":"Br J Dermatol"},{"key":"8633_CR194","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1046\/j.1365-2133.2000.03841.x","volume":"143","author":"D Zillikens","year":"2000","unstructured":"Zillikens D, Ishiko A, Jonkman MF, Chimanovitch I, Shimizu H, Hashimoto T, Brocker EB (2000) Autoantibodies in anti-p200 pemphigoid stain skin lacking laminin 5 and type VII collagen. Br J Dermatol 143:1043\u20131049","journal-title":"Br J Dermatol"},{"key":"8633_CR195","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1067\/mjd.2002.120923","volume":"46","author":"CA Egan","year":"2002","unstructured":"Egan CA, Yee C, Zillikens D, Yancey KB (2002) Anti-p200 pemphigoid: diagnosis and treatment of a case presenting as an inflammatory subepidermal blistering disease. J Am Acad Dermatol 46:786\u2013789","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR196","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.jid.5700952","volume":"128","author":"SC Hofmann","year":"2008","unstructured":"Hofmann SC, Voith U, Sasaki T, Trueb RM, Nischt R, Bruckner-Tuderman L (2008) The autoantigen in anti-p200 pemphigoid is synthesized by keratinocytes and fibroblasts and is distinct from nidogen-2. J Invest Dermatol 128:87\u201395. doi: 10.1038\/sj.jid.5700952","journal-title":"J Invest Dermatol"},{"key":"8633_CR197","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041769","volume":"7","author":"K Vafia","year":"2012","unstructured":"Vafia K, Groth S, Beckmann T, Hirose M, Dworschak J, Recke A, Ludwig RJ, Hashimoto T, Zillikens D, Schmidt E (2012) Pathogenicity of autoantibodies in anti-p200 pemphigoid. PLoS One 7:e41769. doi: 10.1371\/journal.pone.0041769","journal-title":"PLoS One"},{"key":"8633_CR198","doi-asserted-by":"publisher","unstructured":"Wozniak K, Hashimoto T, Fukuda S, Ohyama B, Ishii N, Koga H, Dainichi T, Kowalewski C (2011) IgA anti-p200 pemphigoid. Arch Dermatol 147:1306-1310. 10.1001\/archdermatol.2011.303","DOI":"10.1001\/archdermatol.2011.303"},{"key":"8633_CR199","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000182268","volume":"218","author":"Y Goto-Ohguchi","year":"2009","unstructured":"Goto-Ohguchi Y, Nishie W, Akiyama M, Tateishi Y, Aoyagi S, Tsuji-Abe Y, Sawamura D, Ishii N, Hashimoto T, Shimizu H (2009) A severe and refractory case of anti-p200 pemphigoid resulting in multiple skin ulcers and scar formation. Dermatology 218:265\u2013271. doi: 10.1159\/000182268","journal-title":"Dermatology"},{"key":"8633_CR200","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/j.1365-2133.2008.08483.x","volume":"158","author":"J Mitsuya","year":"2008","unstructured":"Mitsuya J, Hara H, Ito K, Ishii N, Hashimoto T, Terui T (2008) Metastatic ovarian carcinoma-associated subepidermal blistering disease with autoantibodies to both the p200 dermal antigen and the gamma 2 subunit of laminin 5 showing unusual clinical features. Br J Dermatol 158:1354\u20131357. doi: 10.1111\/j.1365-2133.2008.08483.x","journal-title":"Br J Dermatol"},{"key":"8633_CR201","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1159\/000092292","volume":"212","author":"T Yamada","year":"2006","unstructured":"Yamada T, Suzuki M, Koike Y, Kida K, Murata S, Ishii N, Hashimoto T, Ohtsuki M (2006) A case of epidermolysis bullosa acquisita with autoantibody to anti-p200 pemphigoid antigen and exfoliative esophagitis. Dermatology 212:381\u2013384. doi: 10.1159\/000092292","journal-title":"Dermatology"},{"key":"8633_CR202","doi-asserted-by":"publisher","unstructured":"Pastar Z, Rados J, Lipozencic J, Dobric I, Marinovic B, Ishii N, Hashimoto T (2007) Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid\u2014how to treat it? Int J Dermatol 46:295\u2013298. doi: 10.1111\/j.1365-4632.2006.02969.x","DOI":"10.1111\/j.1365-4632.2006.02969.x"},{"key":"8633_CR203","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1001\/jamadermatol.2013.5358","volume":"149","author":"M Kamata","year":"2013","unstructured":"Kamata M, Fujita H, Hamanaka T, Takahashi K, Koga H, Hashimoto T, Sato S (2013) Anti-laminin gamma1 pemphigoid accompanied by autoantibodies to laminin alpha3 and gamma2 subunits of laminin-332. JAMA Dermatol 149:1437\u20131439. doi: 10.1001\/jamadermatol.2013.5358","journal-title":"JAMA Dermatol"},{"key":"8633_CR204","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/bjd.13107","volume":"171","author":"X Li","year":"2014","unstructured":"Li X, Qian H, Ishii N, Yamaya M, Fukuda H, Mukai H, Hirako Y, Hashimoto T (2014) A case of concurrent antilaminin gamma1 pemphigoid and antilaminin-332-type mucous membrane pemphigoid. Br J Dermatol 171:1257\u20131259. doi: 10.1111\/bjd.13107","journal-title":"Br J Dermatol"},{"key":"8633_CR205","doi-asserted-by":"publisher","unstructured":"Colognato H, Yurchenco PD (2000) Form and function: the laminin family of heterotrimers. Dev Dyn 218:213-234. 10.1002\/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R","DOI":"10.1002\/(SICI)1097-0177(200006)218:2%3C213::AID-DVDY1%3E3.0.CO;2-R"},{"key":"8633_CR206","doi-asserted-by":"publisher","unstructured":"Rose C, Weyers W, Denisjuk N, Hillen U, Zillikens D, Shimanovich I (2007) Histopathology of anti-p200 pemphigoid. Am J Dermatopathol 29:119-124. 10.1097\/DAD.0b013e31803326e6","DOI":"10.1097\/DAD.0b013e31803326e6"},{"key":"8633_CR207","doi-asserted-by":"publisher","unstructured":"Koga H, Ishii N, Dainichi T, Tsuruta D, Hamada T, Ohata C, Karashima T, Furumura M, Hashimoto T (2013) An attempt to develop mouse model for anti-laminin gamma1 pemphigoid. J Dermatol Sci 70:108-115. 10.1016\/j.jdermsci.2013.01.001","DOI":"10.1016\/j.jdermsci.2013.01.001"},{"key":"8633_CR208","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ajpath.2013.10.019","volume":"184","author":"F Florea","year":"2014","unstructured":"Florea F, Bernards C, Caproni M, Kleindienst J, Hashimoto T, Koch M, Sitaru C (2014) Ex vivo pathogenicity of anti-laminin gamma1 autoantibodies. Am J Pathol 184:494\u2013506. doi: 10.1016\/j.ajpath.2013.10.019","journal-title":"Am J Pathol"},{"key":"8633_CR209","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1365-2133.2008.08965.x","volume":"160","author":"H Iwata","year":"2009","unstructured":"Iwata H, Hiramitsu Y, Aoyama Y, Kitajima Y (2009) A case of anti-p200 pemphigoid: evidence for a different pathway in neutrophil recruitment compared with bullous pemphigoid. Br J Dermatol 160:462\u2013464. doi: 10.1111\/j.1365-2133.2008.08965.x","journal-title":"Br J Dermatol"},{"key":"8633_CR210","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1111\/bjd.12163","volume":"168","author":"Y Majima","year":"2013","unstructured":"Majima Y, Yagi H, Tateishi C, Groth S, Schmidt E, Zillikens D, Koga H, Hashimoto T, Tokura Y (2013) A successful treatment with ustekinumab in a case of antilaminin-gamma1 pemphigoid associated with psoriasis. Br J Dermatol 168:1367\u20131369. doi: 10.1111\/bjd.12163","journal-title":"Br J Dermatol"},{"key":"8633_CR211","doi-asserted-by":"crossref","unstructured":"Kasperkiewicz M, Hoppe U, Zillikens D, Schmidt E (2009) Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid. Clin Exp Dermatol in press","DOI":"10.1111\/j.1365-2230.2009.03731.x"},{"key":"8633_CR212","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/jdv.12352","volume":"28","author":"A Alloo","year":"2014","unstructured":"Alloo A, Strazzula L, Rothschild B, Hawryluk E, Levine D, Hoang MP, Koga H, Hashimoto T, Kroshinsky D (2014) Refractory antilaminin gamma1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetil. J Eur Acad Dermatol Venereol 28:1401\u20131403. doi: 10.1111\/jdv.12352","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8633_CR213","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1684\/ejd.2013.2138","volume":"23","author":"C Ohata","year":"2013","unstructured":"Ohata C, Fukuda S, Ishii N, Koga H, Hamada T, Furumura M, Hashimoto T (2013) Refractory anti-laminin gamma1 pemphigoid with psoriasis vulgaris successfully treated by double-filtration plasmapheresis. Eur J Dermatol 23:715\u2013716. doi: 10.1684\/ejd.2013.2138","journal-title":"Eur J Dermatol"},{"key":"8633_CR214","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJM198404193101602","volume":"310","author":"DT Woodley","year":"1984","unstructured":"Woodley DT, Briggaman RA, O'Keefe EJ, Inman AO, Queen LL, Gammon WR (1984) Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 310:1007\u20131013","journal-title":"N Engl J Med"},{"key":"8633_CR215","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","volume":"131","author":"P Bernard","year":"1995","unstructured":"Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux JP, Lorette G, Bonnetblanc JM, Prost C (1995) Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 131:48\u201352","journal-title":"Arch Dermatol"},{"key":"8633_CR216","doi-asserted-by":"publisher","unstructured":"Hubner F, Recke A, Zillikens D, Linder R, Schmidt E (2016) Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany. J Invest Dermatol. doi: 10.1016\/j.jid.2016.07.013","DOI":"10.1016\/j.jid.2016.07.013"},{"key":"8633_CR217","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/1523-1747.ep12470317","volume":"91","author":"WR Gammon","year":"1988","unstructured":"Gammon WR, Heise ER, Burke WA, Fine JD, Woodley DT, Briggaman RA (1988) Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol 91:228\u2013232","journal-title":"J Invest Dermatol"},{"key":"8633_CR218","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1038\/jid.2011.231","volume":"131","author":"C Zumelzu","year":"2011","unstructured":"Zumelzu C, Le Roux-Villet C, Loiseau P, Busson M, Heller M, Aucouturier F, Pendaries V, Lievre N, Pascal F, Brette MD, Doan S, Charron D, Caux F, Laroche L, Petit A, Prost-Squarcioni C (2011) Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita. J Invest Dermatol 131:2386\u20132393. jid2011231 [pii]. doi: 10.1038\/jid.2011.231","journal-title":"J Invest Dermatol"},{"key":"8633_CR219","doi-asserted-by":"publisher","unstructured":"Zhao CY, Murrell DF Autoimmune blistering diseases in females: a review. International Journal of Women's Dermatology 1:4\u201312. 10.1016\/j.ijwd.2015.01.002","DOI":"10.1016\/j.ijwd.2015.01.002"},{"key":"8633_CR220","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/1744666x.2016.1221343","volume":"13","author":"A Vorobyev","year":"2017","unstructured":"Vorobyev A, Ludwig RJ, Schmidt E (2017) Clinical features and diagnosis of epidermolysis bullosa acquisita. Expert Rev Clin Immunol 13:157\u2013169. doi: 10.1080\/1744666x.2016.1221343","journal-title":"Expert Rev Clin Immunol"},{"key":"8633_CR221","doi-asserted-by":"publisher","unstructured":"Schmidt E, Zillikens D (2011) The diagnosis and treatment of autoimmune blistering skin diseases. Dtsch Arztebl Int 108:399-405, i-iii. 10.3238\/arztebl.2011.0405","DOI":"10.3238\/arztebl.2011.0405"},{"key":"8633_CR222","doi-asserted-by":"crossref","unstructured":"Prost Squarcioni C, Caux F (2015). Epidermolysis Bullosa Berlin Heidelberg","DOI":"10.1007\/978-3-662-45698-9_61"},{"issue":"301\u2013307","key":"8633_CR223","doi-asserted-by":"publisher","first-page":"ix","DOI":"10.1016\/j.det.2011.11.008","volume":"30","author":"DF Sebaratnam","year":"2012","unstructured":"Sebaratnam DF, Frew JW, Davatchi F, Murrell DF (2012) Quality-of-life measurement in blistering diseases. Dermatol Clin 30(301\u2013307):ix. doi: 10.1016\/j.det.2011.11.008","journal-title":"Dermatol Clin"},{"key":"8633_CR224","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/bjd.12308","volume":"169","author":"JB Terra","year":"2013","unstructured":"Terra JB, Meijer JM, Jonkman MF, Diercks GF (2013) The n- vs. u-serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis. Br J Dermatol 169:100\u2013105. doi: 10.1111\/bjd.12308","journal-title":"Br J Dermatol"},{"key":"8633_CR225","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2133.2004.06006.x","volume":"151","author":"RM Vodegel","year":"2004","unstructured":"Vodegel RM, Jonkman MF, Pas HH, de Jong MC (2004) U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol 151:112\u2013118. doi: 10.1111\/j.1365-2133.2004.06006.x","journal-title":"Br J Dermatol"},{"key":"8633_CR226","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.jaad.2011.12.032","volume":"68","author":"L Komorowski","year":"2013","unstructured":"Komorowski L, Muller R, Vorobyev A, Probst C, Recke A, Jonkman MF, Hashimoto T, Kim SC, Groves R, Ludwig RJ, Zillikens D, Stocker W, Schmidt E (2013) Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. J Am Acad Dermatol 68:e89\u2013e95. doi: 10.1016\/j.jaad.2011.12.032","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR227","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jdermsci.2011.03.003","volume":"62","author":"MA Saleh","year":"2011","unstructured":"Saleh MA, Ishii K, Kim YJ, Murakami A, Ishii N, Hashimoto T, Schmidt E, Zillikens D, Shirakata Y, Hashimoto K, Kitajima Y, Amagai M (2011) Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients. J Dermatol Sci 62:169\u2013175. doi: 10.1016\/j.jdermsci.2011.03.003","journal-title":"J Dermatol Sci"},{"key":"8633_CR228","doi-asserted-by":"publisher","unstructured":"van Beek N, Dahnrich C, Johannsen N et al (2016) Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases. J Am Acad Dermatol. doi: 10.1016\/j.jaad.2016.11.002","DOI":"10.1016\/j.jaad.2016.11.002"},{"key":"8633_CR229","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/jdv.12129","volume":"28","author":"V Calabresi","year":"2014","unstructured":"Calabresi V, Sinistro A, Cozzani E, Cerasaro C, Lolicato F, Muscianese M, Parodi A, Didona B, Zambruno G, Di Zenzo G (2014) Sensitivity of different assays for the serological diagnosis of epidermolysis bullosa acquisita: analysis of a cohort of 24 Italian patients. J Eur Acad Dermatol Venereol 28:483\u2013490. doi: 10.1111\/jdv.12129","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8633_CR230","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jaad.2016.01.005","volume":"74","author":"V Seta","year":"2016","unstructured":"Seta V, Aucouturier F, Bonnefoy J, Le Roux-Villet C, Pendaries V, Alexandre M, Grootenboer-Mignot S, Heller M, Lievre N, Laroche L, Caux F, Titeux M, Hovnanian A, Prost-Squarcioni C (2016) Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA). J Am Acad Dermatol 74:1166\u20131172. doi: 10.1016\/j.jaad.2016.01.005","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR231","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/1523-1747.ep12285634","volume":"108","author":"M Chen","year":"1997","unstructured":"Chen M, Chan LS, Cai X, O'Toole EA, Sample JC, Woodley DT (1997) Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 108:68\u201372","journal-title":"J Invest Dermatol"},{"key":"8633_CR232","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archderm.1996.03890260053008","volume":"132","author":"MC Jong De","year":"1996","unstructured":"De Jong MC, Bruins S, Heeres K, Jonkman MF, Nieboer C, Boorsma DM, Pas HH, van der Meer JB (1996) Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping. Arch Dermatol 132:151\u2013157","journal-title":"Arch Dermatol"},{"key":"8633_CR233","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/1523-1747.ep12526124","volume":"76","author":"H Yaoita","year":"1981","unstructured":"Yaoita H, Briggaman RA, Lawley TJ, Provost TT, Katz SI (1981) Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol 76:288\u2013292","journal-title":"J Invest Dermatol"},{"key":"8633_CR234","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1984.tb07305.x","volume":"110","author":"C Prost","year":"1984","unstructured":"Prost C, Dubertret L, Fosse M, Wechsler J, Touraine R (1984) A routine immuno-electron microscopic technique for localizing an auto-antibody on epidermal basement membrane. Br J Dermatol 110:1\u20137","journal-title":"Br J Dermatol"},{"key":"8633_CR235","volume-title":"Electron microscopy and immunoelectron microscopy","author":"C Prost Squarcioni","year":"2015","unstructured":"Prost Squarcioni C (2015). Electron microscopy and immunoelectron microscopy. Berlin Heidelberg"},{"key":"8633_CR236","doi-asserted-by":"publisher","first-page":"812029","DOI":"10.1155\/2013\/812029","volume":"2013","author":"RJ Ludwig","year":"2013","unstructured":"Ludwig RJ (2013) Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita. ISRN Dermatol 2013:812029. doi: 10.1155\/2013\/812029","journal-title":"ISRN Dermatol"},{"key":"8633_CR237","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/JID.2015.356","volume":"136","author":"M Kasperkiewicz","year":"2016","unstructured":"Kasperkiewicz M, Sadik CD, Bieber K, Ibrahim SM, Manz RA, Schmidt E, Zillikens D, Ludwig RJ (2016) Epidermolysis bullosa acquisita: from pathophysiology to novel therapeutic options. J Invest Dermatol 136:24\u201333. doi: 10.1038\/JID.2015.356","journal-title":"J Invest Dermatol"},{"key":"8633_CR238","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/08916934.2011.606447","volume":"45","author":"M Kasperkiewicz","year":"2011","unstructured":"Kasperkiewicz M, Zillikens D, Schmidt E (2011) Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity 45:55\u201370. doi: 10.3109\/08916934.2011.606447","journal-title":"Autoimmunity"},{"key":"8633_CR239","volume-title":"Epidermolysis Bullosa","author":"C Prost-Squarcioni","year":"2015","unstructured":"Prost-Squarcioni C, Caux F (2015) Epidermolysis Bullosa. Berlin, Heidelberg"},{"key":"8633_CR240","doi-asserted-by":"publisher","unstructured":"Kirtschig G, Murrell D, Wojnarowska F, Khumalo N (2003) Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. Cochrane Database Syst Rev:Cd004056. 10.1002\/14651858.cd004056","DOI":"10.1002\/14651858.cd004056"},{"key":"8633_CR241","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.det.2011.06.020","volume":"29","author":"LR Intong","year":"2011","unstructured":"Intong LR, Murrell DF (2011) Management of epidermolysis bullosa acquisita. Dermatol Clin 29:643\u2013647. doi: 10.1016\/j.det.2011.06.020","journal-title":"Dermatol Clin"},{"key":"8633_CR242","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clindermatol.2011.03.011","volume":"30","author":"R Gupta","year":"2012","unstructured":"Gupta R, Woodley DT, Chen M (2012) Epidermolysis bullosa acquisita. Clin Dermatol 30:60\u201369. doi: 10.1016\/j.clindermatol.2011.03.011","journal-title":"Clin Dermatol"},{"key":"8633_CR243","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archderm.142.2.147","volume":"142","author":"E Schmidt","year":"2006","unstructured":"Schmidt E, Benoit S, Brocker EB, Zillikens D, Goebeler M (2006) Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab. Arch Dermatol 142:147\u2013150","journal-title":"Arch Dermatol"},{"key":"8633_CR244","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12016-007-8021-6","volume":"34","author":"E Schmidt","year":"2008","unstructured":"Schmidt E, Brocker EB, Goebeler M (2008) Rituximab in treatment-resistant autoimmune blistering skin disorders. Clin Rev Allergy Immunol 34:56\u201364","journal-title":"Clin Rev Allergy Immunol"},{"key":"8633_CR245","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.det.2011.06.023","volume":"29","author":"BS Daniel","year":"2011","unstructured":"Daniel BS, Murrell DF, Joly P (2011) Rituximab and its use in autoimmune bullous disorders. Dermatol Clin 29:571\u2013575. doi: 10.1016\/j.det.2011.06.023","journal-title":"Dermatol Clin"},{"key":"8633_CR246","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.det.2011.06.010","volume":"29","author":"SN Chee","year":"2011","unstructured":"Chee SN, Murrell DF (2011) The use of intravenous immunoglobulin in autoimmune bullous diseases. Dermatol Clin 29:565\u2013570. doi: 10.1016\/j.det.2011.06.010","journal-title":"Dermatol Clin"},{"key":"8633_CR247","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00403-009-1024-9","volume":"302","author":"E Schmidt","year":"2010","unstructured":"Schmidt E, Zillikens D (2010) Immunoadsorption in dermatology. Arch Dermatol Res 302:241\u2013253","journal-title":"Arch Dermatol Res"},{"key":"8633_CR248","volume-title":"The pathogenesis, assessment and management of pruritus in autoimmune bullous diseases","author":"F Brennan","year":"2015","unstructured":"Brennan F, Lim C (2015). The pathogenesis, assessment and management of pruritus in autoimmune bullous diseases;. Berlin Heidelberg"},{"key":"8633_CR249","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archderm.131.8.957","volume":"131","author":"D Zillikens","year":"1995","unstructured":"Zillikens D, Wever S, Roth A, Weidenthaler-Barth B, Hashimoto T, Brocker EB (1995) Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 131:957\u2013958","journal-title":"Arch Dermatol"},{"key":"8633_CR250","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/eye.2012.119","volume":"26","author":"CF Radford","year":"2012","unstructured":"Radford CF, Rauz S, Williams GP, Saw VP, Dart JK (2012) Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom. Eye (Lond) 26:1199\u20131208. doi: 10.1038\/eye.2012.119","journal-title":"Eye (Lond)"},{"key":"8633_CR251","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/1523-1747.ep12332352","volume":"108","author":"LS Chan","year":"1997","unstructured":"Chan LS, Hammerberg C, Cooper KD (1997) Significantly increased occurrence of HLA-DQB1*0301 allele in patients with ocular cicatricial pemphigoid. J Invest Dermatol 108:129\u2013132","journal-title":"J Invest Dermatol"},{"key":"8633_CR252","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2133.2001.04448.x","volume":"145","author":"M Carrozzo","year":"2001","unstructured":"Carrozzo M, Fasano ME, Broccoletti R, Carbone M, Cozzani E, Rendine S, Roggero S, Parodi A, Gandolfo S (2001) HLA-DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity. Br J Dermatol 145:805\u2013808","journal-title":"Br J Dermatol"},{"key":"8633_CR253","first-page":"370","volume":"138","author":"LS Chan","year":"2002","unstructured":"Chan LS, Ahmed AR, Anhalt GJ et al (2002) The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 138:370\u2013379","journal-title":"Arch Dermatol"},{"key":"8633_CR254","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jaad.2014.08.024","volume":"72","author":"DF Murrell","year":"2015","unstructured":"Murrell DF, Marinovic B, Caux F et al (2015) Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. J Am Acad Dermatol 72:168\u2013174. doi: 10.1016\/j.jaad.2014.08.024","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR255","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/s0140-6736(00)04971-0","volume":"357","author":"CA Egan","year":"2001","unstructured":"Egan CA, Lazarova Z, Darling TN, Yee C, Cote T, Yancey KB (2001) Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet 357:1850\u20131851. doi: 10.1016\/s0140-6736(00)04971-0","journal-title":"Lancet"},{"key":"8633_CR256","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1346-8138.2004.tb00497.x","volume":"31","author":"S Matsushima","year":"2004","unstructured":"Matsushima S, Horiguchi Y, Honda T, Fujii S, Okano T, Tanabe M, Wakayama T, Hashimoto T, Yancey KB (2004) A case of anti-epiligrin cicatricial pemphigoid associated with lung carcinoma and severe laryngeal stenosis: review of Japanese cases and evaluation of risk for internal malignancy. J Dermatol 31:10\u201315","journal-title":"J Dermatol"},{"key":"8633_CR257","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jamadermatol.2013.4972","volume":"149","author":"DF Sebaratnam","year":"2013","unstructured":"Sebaratnam DF, Hanna AM, Chee SN, Frew JW, Venugopal SS, Daniel BS, Martin LK, Rhodes LM, Tan JC, Wang CQ, Welsh B, Nijsten T, Murrell DF (2013) Development of a quality-of-life instrument for autoimmune bullous disease: the autoimmune bullous disease quality of life questionnaire. JAMA Dermatol 149:1186\u20131191. doi: 10.1001\/jamadermatol.2013.4972","journal-title":"JAMA Dermatol"},{"key":"8633_CR258","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/bjd.12623","volume":"169","author":"A Tjokrowidjaja","year":"2013","unstructured":"Tjokrowidjaja A, Daniel BS, Frew JW, Sebaratnam DF, Hanna AM, Chee S, Dermawan A, Wang CQ, Lim C, Venugopal SS, Rhodes LM, Welsh B, Nijsten T, Murrell DF (2013) The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease. Br J Dermatol 169:1000\u20131006. doi: 10.1111\/bjd.12623","journal-title":"Br J Dermatol"},{"key":"8633_CR259","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1067\/mjd.2001.114746","volume":"45","author":"M Megahed","year":"2001","unstructured":"Megahed M, Schmiedeberg S, Becker J, Ruzicka T (2001) Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent. J Am Acad Dermatol 45:256\u2013259. doi: 10.1067\/mjd.2001.114746","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0151-9638(05)79188-2","volume":"132","author":"S Ingen-Housz-Oro","year":"2005","unstructured":"Ingen-Housz-Oro S, Prost-Squarcioni C, Pascal F, Doan S, Brette MD, Bachelez H, Dubertret L (2005) Cicatricial pemphigoid: treatment with mycophenolate mofetil. Ann Dermatol Venereol 132:13\u201316","journal-title":"Ann Dermatol Venereol"},{"key":"8633_CR261","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3109\/09273948.2011.624288","volume":"19","author":"D Doycheva","year":"2011","unstructured":"Doycheva D, Deuter C, Blumenstock G, Stuebiger N, Zierhut M (2011) Long-term results of therapy with mycophenolate mofetil in ocular mucous membrane pemphigoid. Ocul Immunol Inflamm 19:431\u2013438. doi: 10.3109\/09273948.2011.624288","journal-title":"Ocul Immunol Inflamm"},{"key":"8633_CR262","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/bjd.12041","volume":"168","author":"EM Munyangango","year":"2013","unstructured":"Munyangango EM, Le Roux-Villet C, Doan S, Pascal F, Soued I, Alexandre M, Heller M, Lievre N, Aucouturier F, Caux F, Laroche L, Prost-Squarcioni C (2013) Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid. Br J Dermatol 168:381\u2013390. doi: 10.1111\/bjd.12041","journal-title":"Br J Dermatol"},{"key":"8633_CR263","first-page":"101","volume":"137","author":"P Musette","year":"2001","unstructured":"Musette P, Pascal F, Hoang-Xuan T, Heller M, Lok C, Deboise A, Dubertret L, Prost C (2001) Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide. Arch Dermatol 137:101\u2013102","journal-title":"Arch Dermatol"},{"key":"8633_CR264","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.ophtha.2009.09.049","volume":"117","author":"CS Foster","year":"2010","unstructured":"Foster CS, Chang PY, Ahmed AR (2010) Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report. Ophthalmology 117:861\u2013869. doi: 10.1016\/j.ophtha.2009.09.049","journal-title":"Ophthalmology"},{"key":"8633_CR265","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/archdermatol.2011.54","volume":"147","author":"C Roux-Villet Le","year":"2011","unstructured":"Le Roux-Villet C, Prost-Squarcioni C, Alexandre M, Caux F, Pascal F, Doan S, Brette MD, Soued I, Gabison E, Aucouturier F, Letestu R, Laroche L, Bachelez H (2011) Rituximab for patients with refractory mucous membrane pemphigoid. Arch Dermatol 147:843\u2013849. doi: 10.1001\/archdermatol.2011.54","journal-title":"Arch Dermatol"},{"key":"8633_CR266","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/j.1468-3083.2010.03889.x","volume":"25","author":"S Lourari","year":"2011","unstructured":"Lourari S, Herve C, Doffoel-Hantz V, Meyer N, Bulai-Livideanu C, Viraben R, Maza A, Adoue D, Bedane C, Paul C (2011) Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients. J Eur Acad Dermatol Venereol 25:1238\u20131240. doi: 10.1111\/j.1468-3083.2010.03889.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8633_CR267","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2310\/7750.2014.14004","volume":"18","author":"C Sladden","year":"2014","unstructured":"Sladden C, Kirchhof MG, Crawford RI (2014) Biopsy location for direct immunofluorescence in patients with suspected bullous pemphigoid impacts probability of a positive test result. J Cutan Med Surg 18:392\u2013396. doi: 10.2310\/7750.2014.14004","journal-title":"J Cutan Med Surg"},{"key":"8633_CR268","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/ddg.12612","volume":"13","author":"E Schmidt","year":"2015","unstructured":"Schmidt E, Goebeler M, Hertl M, Sardy M, Sitaru C, Eming R, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Orzechowski HD, Pfeiffer C, Schuster V, Sporbeck B, Sticherling M, Worm M, Zillikens D, Nast A (2015) S2k guideline for the diagnosis of pemphigus vulgaris\/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges 13:713\u2013727. doi: 10.1111\/ddg.12612","journal-title":"J Dtsch Dermatol Ges"},{"key":"8633_CR269","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/bjd.14686","volume":"175","author":"S Glauser","year":"2016","unstructured":"Glauser S, Rutz M, Cazzaniga S, Hegyi I, Borradori L, Beltraminelli H (2016) Diagnostic value of immunohistochemistry on formalin-fixed, paraffin-embedded skin biopsy specimens for bullous pemphigoid. Br J Dermatol 175:988\u2013993. doi: 10.1111\/bjd.14686","journal-title":"Br J Dermatol"},{"key":"8633_CR270","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jaad.2013.07.009","volume":"69","author":"M Sardy","year":"2013","unstructured":"Sardy M, Kostaki D, Varga R, Peris K, Ruzicka T (2013) Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid. J Am Acad Dermatol 69:748\u2013753. doi: 10.1016\/j.jaad.2013.07.009","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR271","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4103\/0019-5154.135488","volume":"59","author":"AC Buch","year":"2014","unstructured":"Buch AC, Kumar H, Panicker N, Misal S, Sharma Y, Gore CR (2014) A cross-sectional study of direct immunofluorescence in the diagnosis of immunobullous dermatoses. Indian J Dermatol 59:364\u2013368. doi: 10.4103\/0019-5154.135488","journal-title":"Indian J Dermatol"},{"key":"8633_CR272","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1365-4362.1998.00271.x","volume":"37","author":"GC Chaidemenos","year":"1998","unstructured":"Chaidemenos GC, Maltezos E, Chrysomallis F, Kouskoukis K, Kapetis E, Mourellou O, Gotsis N (1998) Value of routine diagnostic criteria of bullous pemphigoid. Int J Dermatol 37:206\u2013210","journal-title":"Int J Dermatol"},{"key":"8633_CR273","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4103\/2229-5178.156386","volume":"6","author":"VV Mysorekar","year":"2015","unstructured":"Mysorekar VV, Sumathy TK, Shyam Prasad AL (2015) Role of direct immunofluorescence in dermatological disorders. Indian Dermatol Online J 6:172\u2013180. doi: 10.4103\/2229-5178.156386","journal-title":"Indian Dermatol Online J"},{"key":"8633_CR274","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","volume":"134","author":"L Vaillant","year":"1998","unstructured":"Vaillant L, Bernard P, Joly P, Prost C, Labeille B, Bedane C, Arbeille B, Thomine E, Bertrand P, Lok C, Roujeau JC (1998) Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol 134:1075\u20131080","journal-title":"Arch Dermatol"},{"issue":"365\u2013372","key":"8633_CR275","doi-asserted-by":"publisher","first-page":"vii","DOI":"10.1016\/j.det.2011.03.001","volume":"29","author":"G Pohla-Gubo","year":"2011","unstructured":"Pohla-Gubo G, Hintner H (2011) Direct and indirect immunofluorescence for the diagnosis of bullous autoimmune diseases. Dermatol Clin 29(365\u2013372):vii. doi: 10.1016\/j.det.2011.03.001","journal-title":"Dermatol Clin"},{"key":"8633_CR276","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2133.1988.tb01747.x","volume":"118","author":"SE Kelly","year":"1988","unstructured":"Kelly SE, Wojnarowska F (1988) The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Br J Dermatol 118:31\u201340","journal-title":"Br J Dermatol"},{"key":"8633_CR277","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archderm.1997.03890450048006","volume":"133","author":"RF Ghohestani","year":"1997","unstructured":"Ghohestani RF, Nicolas JF, Rousselle P, Claudy AL (1997) Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol 133:1102\u20131107","journal-title":"Arch Dermatol"},{"key":"8633_CR278","doi-asserted-by":"publisher","first-page":"677","DOI":"10.4103\/0378-6323.86479","volume":"77","author":"B Yang","year":"2011","unstructured":"Yang B, Wang C, Chen S, Chen X, Zhou G, Tian H, Yu M, Zhang D, Shi Z, Zhang F (2011) Accuracy of indirect immunofluorescence on sodium chloride-split skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. Indian J Dermatol Venereol Leprol 77:677\u2013682. doi: 10.4103\/0378-6323.86479","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"8633_CR279","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/15665240113136660079","volume":"14","author":"JV Otten","year":"2014","unstructured":"Otten JV, Hashimoto T, Hertl M, Payne AS, Sitaru C (2014) Molecular diagnosis in autoimmune skin blistering conditions. Curr Mol Med 14:69\u201395","journal-title":"Curr Mol Med"},{"key":"8633_CR280","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1600-0625.2007.00592.x","volume":"16","author":"C Sitaru","year":"2007","unstructured":"Sitaru C, Dahnrich C, Probst C, Komorowski L, Blocker I, Schmidt E, Schlumberger W, Rose C, Stocker W, Zillikens D (2007) Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol 16:770\u2013777. doi: 10.1111\/j.1600-0625.2007.00592.x","journal-title":"Exp Dermatol"},{"key":"8633_CR281","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1365-2133.2012.10820.x","volume":"166","author":"IM Blocker","year":"2012","unstructured":"Blocker IM, Dahnrich C, Probst C, Komorowski L, Saschenbrecker S, Schlumberger W, Stocker W, Zillikens D, Schmidt E (2012) Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid. Br J Dermatol 166:964\u2013970. doi: 10.1111\/j.1365-2133.2012.10820.x","journal-title":"Br J Dermatol"},{"key":"8633_CR282","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/01.AOG.0000115506.76104.ad","volume":"103","author":"C Sitaru","year":"2004","unstructured":"Sitaru C, Powell J, Messer G, Brocker EB, Wojnarowska F, Zillikens D (2004) Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. Obstet Gynecol 103:757\u2013763. doi: 10.1097\/01.AOG.0000115506.76104.ad","journal-title":"Obstet Gynecol"},{"key":"8633_CR283","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.clindermatol.2016.02.010","volume":"34","author":"CD Sadik","year":"2016","unstructured":"Sadik CD, Lima AL, Zillikens D (2016) Pemphigoid gestationis: toward a better understanding of the etiopathogenesis. Clin Dermatol 34:378\u2013382. doi: 10.1016\/j.clindermatol.2016.02.010","journal-title":"Clin Dermatol"},{"key":"8633_CR284","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","volume":"136","author":"E Schmidt","year":"2000","unstructured":"Schmidt E, Obe K, Brocker EB, Zillikens D (2000) Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 136:174\u2013178","journal-title":"Arch Dermatol"},{"key":"8633_CR285","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/archdermatol.2011.23","volume":"147","author":"J Charneux","year":"2011","unstructured":"Charneux J, Lorin J, Vitry F, Antonicelli F, Reguiai Z, Barbe C, Tabary T, Grange F, Bernard P (2011) Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients. Arch Dermatol 147:286\u2013291. doi: 10.1001\/archdermatol.2011.23","journal-title":"Arch Dermatol"},{"key":"8633_CR286","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","volume":"128","author":"G Zenzo Di","year":"2008","unstructured":"Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, Wieslander J, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M (2008) Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin Immunol 128:415\u2013426. doi: 10.1016\/j.clim.2008.04.012","journal-title":"Clin Immunol"},{"key":"8633_CR287","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.clim.2003.12.007","volume":"111","author":"A Kromminga","year":"2004","unstructured":"Kromminga A, Sitaru C, Hagel C, Herzog S, Zillikens D (2004) Development of an ELISA for the detection of autoantibodies to BP230. Clin Immunol 111:146\u2013152. doi: 10.1016\/j.clim.2003.12.007","journal-title":"Clin Immunol"},{"key":"8633_CR288","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000337545","volume":"224","author":"L Sache-de Peufeilhoux Le","year":"2012","unstructured":"Le Sache-de Peufeilhoux L, Ingen-Housz-Oro S, Hue S, Sbidian E, Valeyrie-Allanore L, Ortonne N, Roujeau JC, Wolkenstein P, Chosidow O, Andre C (2012) The value of BP230 enzyme-linked immunosorbent assay in the diagnosis and immunological follow-up of bullous pemphigoid. Dermatology 224:154\u2013159. doi: 10.1159\/000337545","journal-title":"Dermatology"},{"key":"8633_CR289","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00403-016-1631-1","volume":"308","author":"JJ Keller","year":"2016","unstructured":"Keller JJ, Kittridge AL, Debanne SM, Korman NJ (2016) Evaluation of ELISA testing for BP180 and BP230 as a diagnostic modality for bullous pemphigoid: a clinical experience. Arch Dermatol Res 308:269\u2013272. doi: 10.1007\/s00403-016-1631-1","journal-title":"Arch Dermatol Res"},{"key":"8633_CR290","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000381143","volume":"231","author":"S Ingen-Housz-Oro","year":"2015","unstructured":"Ingen-Housz-Oro S, Plee J, Belmondo T, Maizieres M, Pham BN, Hue S, Ortonne N, Durlach A, Wolkenstein P, Chosidow O, Bernard P (2015) Positive direct immunofluorescence is of better value than ELISA-BP180 and ELISA-BP230 values for the prediction of relapse after treatment cessation in bullous pemphigoid: a retrospective study of 97 patients. Dermatology 231:50\u201355. doi: 10.1159\/000381143","journal-title":"Dermatology"},{"key":"8633_CR291","doi-asserted-by":"publisher","first-page":"722","DOI":"10.4103\/0378-6323.102364","volume":"78","author":"B Yang","year":"2012","unstructured":"Yang B, Wang C, Chen S, Chen X, Lu X, Tian H, Yu M, Zhang D, Shi Z, Zhou G, Zhang F (2012) Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid. Indian J Dermatol Venereol Leprol 78:722\u2013727. doi: 10.4103\/0378-6323.102364","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"8633_CR292","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5021\/ad.2012.24.1.45","volume":"24","author":"EH Lee","year":"2012","unstructured":"Lee EH, Kim YH, Kim S, Kim SE, Kim SC (2012) Usefulness of enzyme-linked immunosorbent assay using recombinant BP180 and BP230 for serodiagnosis and monitoring disease activity of bullous pemphigoid. Ann Dermatol 24:45\u201355. doi: 10.5021\/ad.2012.24.1.45","journal-title":"Ann Dermatol"},{"key":"8633_CR293","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.autrev.2012.07.006","volume":"12","author":"M Tampoia","year":"2012","unstructured":"Tampoia M, Giavarina D, Di Giorgio C, Bizzaro N (2012) Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: a systematic review and meta-analysis. Autoimmun Rev 12:121\u2013126. doi: 10.1016\/j.autrev.2012.07.006","journal-title":"Autoimmun Rev"},{"key":"8633_CR294","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1172-7-49","volume":"7","author":"N Beek van","year":"2012","unstructured":"van Beek N, Rentzsch K, Probst C, Komorowski L, Kasperkiewicz M, Fechner K, Bloecker IM, Zillikens D, Stocker W, Schmidt E (2012) Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy. Orphanet J Rare Dis 7:49. doi: 10.1186\/1750-1172-7-49","journal-title":"Orphanet J Rare Dis"},{"key":"8633_CR295","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000339776","volume":"225","author":"M Tampoia","year":"2012","unstructured":"Tampoia M, Zucano A, Villalta D, Antico A, Bizzaro N (2012) Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases. Dermatology 225:37\u201344. doi: 10.1159\/000339776","journal-title":"Dermatology"},{"key":"8633_CR296","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.acthis.2013.12.012","volume":"116","author":"I Russo","year":"2014","unstructured":"Russo I, Saponeri A, Peserico A, Alaibac M (2014) The use of biochip immunofluorescence microscopy for the diagnosis of pemphigus vulgaris. Acta Histochem 116:713\u2013716. doi: 10.1016\/j.acthis.2013.12.012","journal-title":"Acta Histochem"},{"key":"8633_CR297","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1590\/abd1806-4841.20153390","volume":"90","author":"J Gornowicz-Porowska","year":"2015","unstructured":"Gornowicz-Porowska J, Dmochowski M, Pietkiewicz P, Bowszyc-Dmochowska M (2015) Mucosal-dominant pemphigus vulgaris in a captopril-taking woman with angioedema. An Bras Dermatol 90:748\u2013751. doi: 10.1590\/abd1806-4841.20153390","journal-title":"An Bras Dermatol"},{"key":"8633_CR298","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/bjd.12739","volume":"170","author":"N Beek van","year":"2014","unstructured":"van Beek N, Dohse A, Riechert F, Krull V, Recke A, Zillikens D, Schmidt E (2014) Serum autoantibodies against the dermal-epidermal junction in patients with chronic pruritic disorders, elderly individuals and blood donors prospectively recruited. Br J Dermatol 170:943\u2013947. doi: 10.1111\/bjd.12739","journal-title":"Br J Dermatol"},{"key":"8633_CR299","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jid.2016.09.010","volume":"137","author":"N Kokkonen","year":"2017","unstructured":"Kokkonen N, Herukka SK, Huilaja L, Kokki M, Koivisto AM, Hartikainen P, Remes AM, Tasanen K (2017) Increased levels of the bullous pemphigoid BP180 autoantibody are associated with more severe dementia in Alzheimer's disease. J Invest Dermatol 137:71\u201376. doi: 10.1016\/j.jid.2016.09.010","journal-title":"J Invest Dermatol"},{"key":"8633_CR300","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/jdv.13397","volume":"30","author":"KT Amber","year":"2016","unstructured":"Amber KT, Bloom R, Hertl M (2016) A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin-332 IgG with oropharyngeal involvement and the usefulness of ELISA. J Eur Acad Dermatol Venereol 30:72\u201377. doi: 10.1111\/jdv.13397","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8633_CR301","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1001\/jamadermatol.2013.1434","volume":"149","author":"P Bernard","year":"2013","unstructured":"Bernard P, Antonicelli F, Bedane C, Joly P, Le Roux-Villet C, Duvert-Lehembre S, Rousselle P, Prost-Squarcioni C (2013) Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid. JAMA Dermatol 149:533\u2013540. doi: 10.1001\/jamadermatol.2013.1434","journal-title":"JAMA Dermatol"},{"key":"8633_CR302","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.clim.2012.02.003","volume":"143","author":"L Fania","year":"2012","unstructured":"Fania L, Caldarola G, Muller R, Brandt O, Pellicano R, Feliciani C, Hertl M (2012) IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses. Clin Immunol 143:236\u2013245. doi: 10.1016\/j.clim.2012.02.003","journal-title":"Clin Immunol"},{"key":"8633_CR303","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/bjd.12300","volume":"169","author":"JB Terra","year":"2013","unstructured":"Terra JB, Jonkman MF, Diercks GF, Pas HH (2013) Low sensitivity of type VII collagen enzyme-linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis. Br J Dermatol 169:164\u2013167. doi: 10.1111\/bjd.12300","journal-title":"Br J Dermatol"},{"key":"8633_CR304","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2172-13-16","volume":"13","author":"E Licarete","year":"2012","unstructured":"Licarete E, Ganz S, Recknagel MJ, Di Zenzo G, Hashimoto T, Hertl M, Zambruno G, Hundorfean G, Mudter J, Neurath MF, Bruckner-Tuderman L, Sitaru C (2012) Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases. BMC Immunol 13:16. doi: 10.1186\/1471-2172-13-16","journal-title":"BMC Immunol"},{"key":"8633_CR305","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1067\/mjd.2003.99","volume":"48","author":"RM Vodegel","year":"2003","unstructured":"Vodegel RM, de Jong MC, Pas HH, Yancey KB, Jonkman MF (2003) Anti-epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: differentiation by use of indirect immunofluorescence microscopy. J Am Acad Dermatol 48:542\u2013547. doi: 10.1067\/mjd.2003.99","journal-title":"J Am Acad Dermatol"},{"key":"8633_CR306","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.autrev.2010.08.007","volume":"10","author":"E Schmidt","year":"2010","unstructured":"Schmidt E, Zillikens D (2010) Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev 10:84\u201389. doi: 10.1016\/j.autrev.2010.08.007","journal-title":"Autoimmun Rev"},{"key":"8633_CR307","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00403-016-1632-0","volume":"308","author":"AV Marzano","year":"2016","unstructured":"Marzano AV, Cozzani E, Biasin M, Russo I, Alaibac M (2016) The use of biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita. Arch Dermatol Res 308:273\u2013276. doi: 10.1007\/s00403-016-1632-0","journal-title":"Arch Dermatol Res"},{"key":"8633_CR308","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.oooo.2013.12.402","volume":"117","author":"T Hayakawa","year":"2014","unstructured":"Hayakawa T, Furumura M, Fukano H, Li X, Ishii N, Hamada T, Ohata C, Tsuruta D, Shimozato K, Hashimoto T (2014) Diagnosis of oral mucous membrane pemphigoid by means of combined serologic testing. Oral Surg Oral Med Oral Pathol Oral Radiol 117:483\u2013496. doi: 10.1016\/j.oooo.2013.12.402","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"8633_CR309","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1046\/j.1365-2133.1998.02167.x","volume":"138","author":"T Kazama","year":"1998","unstructured":"Kazama T, Yamamoto Y, Hashimoto T, Komai A, Ito M (1998) Application of confocal laser scanning microscopy to differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. Br J Dermatol 138:593\u2013601","journal-title":"Br J Dermatol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-017-8633-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8633-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8633-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T17:18:39Z","timestamp":1692897519000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-017-8633-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":309,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["8633"],"URL":"https:\/\/doi.org\/10.1007\/s12016-017-8633-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727878010.793536971","asserted-by":"object"}]},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,4]]}}}